pmid,title,verdict,reasoning
PMID:10053020,The duty to recontact: attitudes of genetics service providers.,EXCLUDE,Ethical review article
PMID:10339466,Myeloid malignancies induced by alkylating agents in Nf1 mice.,INCLUDE,Animal model of NF1
PMID:10383727,"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.",INCLUDE,Animal model of wound healing
PMID:10433955,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,INCLUDE,Genetic analysis of tumors
PMID:10469340,Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1.,EXCLUDE,Descriptive molecular study
PMID:10517503,Clonal origin of recurrent meningiomas.,EXCLUDE,Clonal origin description
PMID:10547131,"Physicians' decision-making in incompetent elderly patients: a comparative study between Austria, Germany (East, West), and Sweden.",EXCLUDE,Physician decision-making review
PMID:10567424,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,INCLUDE,Protein interaction study
PMID:10572231,"[HNPCC syndrome, microsatellite instability and NF1 gene alteration].",EXCLUDE,Genetic syndrome description
PMID:10591653,Mouse tumor model for neurofibromatosis type 1.,INCLUDE,Mouse tumor model
PMID:10595915,Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.,INCLUDE,Genetic analysis of tumors
PMID:10595919,Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.,INCLUDE,Cell cycle regulation study
PMID:10620616,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,INCLUDE,Genetic animal model
PMID:10625896,Midline and far lateral approaches to foramen magnum lesions.,EXCLUDE,Surgical approach description
PMID:10627474,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,INCLUDE,Drug screening method
PMID:10633134,A search for evidence of somatic mutations in the NF1 gene.,INCLUDE,Mutation screening technique
PMID:10669747,"Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.",INCLUDE,Protein interaction study
PMID:10678181,Nf1 and Gmcsf interact in myeloid leukemogenesis.,INCLUDE,Genetic interaction study
PMID:10684924,Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.,INCLUDE,Molecular biology technique
PMID:10705390,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,INCLUDE,Mutation analysis method
PMID:10712197,Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.,INCLUDE,Genetic mutation analysis
PMID:10712203,Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.,INCLUDE,Protein functional analysis
PMID:10844550,The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.,INCLUDE,Animal model of carcinogenesis
PMID:1086153,Tumours of the adrenal gland and paraganglia.,EXCLUDE,Tumor description
PMID:10887156,Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.,INCLUDE,Conditional animal model
PMID:10900196,Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.,INCLUDE,Single cell molecular analysis
PMID:10940926,"Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin.",EXCLUDE,Cellular migration description
PMID:10978227,An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium.,EXCLUDE,Genetic sequence analysis
PMID:11080503,Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.,INCLUDE,Cellular restoration method
PMID:11106357,Growth in North American white children with neurofibromatosis 1 (NF1).,EXCLUDE,Clinical growth study
PMID:11106646,Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.,INCLUDE,Protein interaction study
PMID:11110599,Malignancy in neurofibromatosis type 1.,EXCLUDE,Clinical review
PMID:11159187,Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.,INCLUDE,Cellular transformation study
PMID:11356864,Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.,INCLUDE,Protein interaction study
PMID:11368764,"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.",INCLUDE,Protein binding analysis
PMID:11380622,Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.,INCLUDE,Gene promoter analysis
PMID:11404331,A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.,INCLUDE,Genetic modifier screening
PMID:11432873,Schwannomin isoform-1 interacts with syntenin via PDZ domains.,INCLUDE,Protein interaction study
PMID:11433044,Quantification of splice variants using real-time PCR.,INCLUDE,Molecular biology technique
PMID:11435472,"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.",INCLUDE,Cellular proliferation study
PMID:11438454,NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.,INCLUDE,Genetic mutation analysis
PMID:11493376,S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi.,EXCLUDE,Cellular marker description
PMID:11517334,Control of Drosophila perineurial glial growth by interacting neurotransmitter-mediated signaling pathways.,EXCLUDE,Developmental biology study
PMID:11533205,Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.,INCLUDE,Genetic interaction study
PMID:11535133,Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.,INCLUDE,Protein interaction study
PMID:11544276,Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.,INCLUDE,In vivo genetic analysis
PMID:11560899,"The protein 4.1, ezrin, radixin, moesin (FERM) domain of Drosophila Coracle, a cytoplasmic component of the septate junction, provides functions essential for embryonic development and imaginal cell proliferation.",EXCLUDE,Developmental biology study
PMID:11593241,Single flap fronto-temporo-orbito-zygomatic craniotomy for skull base lesions.,EXCLUDE,Surgical technique
PMID:11703924,"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.",INCLUDE,Signaling pathway study
PMID:11719502,p21-activated kinase links Rac/Cdc42 signaling to merlin.,INCLUDE,Protein interaction study
PMID:11727199,"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.",INCLUDE,Molecular biology technique
PMID:11733333,Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.,EXCLUDE,Clinical imaging study
PMID:11756419,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,INCLUDE,Protein structural analysis
PMID:11784085,Allele-specific non-CpG methylation of the Nf1 gene during early mouse development.,INCLUDE,Epigenetic analysis
PMID:11809806,"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.",INCLUDE,Cellular cytoskeleton study
PMID:11896214,NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation.,INCLUDE,mRNA localization study
PMID:11906692,Molecular neurobiology of human cognition.,EXCLUDE,Review article
PMID:11937955,[Blue-red macules and pseudoatrophic macules in neurofibromatosis 1].,EXCLUDE,Clinical description
PMID:11950659,Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1.,EXCLUDE,Radiological assessment
PMID:11981218,Adrenalectomy for familial pheochromocytoma in the laparoscopic era.,EXCLUDE,Surgical procedure
PMID:11996670,The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.,INCLUDE,Protein interaction study
PMID:12005317,Treatment of ADHD in neurofibromatosis type 1.,EXCLUDE,Clinical treatment review
PMID:12057013,Complex splicing pattern generates great diversity in human NF1 transcripts.,INCLUDE,Molecular biology technique
PMID:12058348,Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.,EXCLUDE,Genetic syndrome description
PMID:12067169,Vertebral scalloping in neurofibromatosis type 1: a quantitative approach.,EXCLUDE,Radiological assessment
PMID:12077339,Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.,INCLUDE,Genetic animal model
PMID:12078978,A virus-like agent associated with neurofibromatosis in damselfish.,EXCLUDE,Viral association study
PMID:12082543,Mouse models of neurofibromatosis 1 and 2.,INCLUDE,Animal model development
PMID:12088451,"Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.",EXCLUDE,Molecular marker study
PMID:12095621,Quantification of NF1 transcripts reveals novel highly expressed splice variants.,INCLUDE,Molecular biology technique
PMID:12124168,Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.,INCLUDE,Tumor microenvironment study
PMID:12130630,Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.,INCLUDE,Protein degradation study
PMID:12175282,Imaging skin pathology with polarized light.,EXCLUDE,Imaging technique description
PMID:12180143,Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force.,EXCLUDE,Clinical review
PMID:12191989,The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.,INCLUDE,Protein interaction study
PMID:12199909,Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.,INCLUDE,Protein expression study
PMID:12235555,Predictors of the risk of mortality in neurofibromatosis 2.,EXCLUDE,Clinical mortality study
PMID:12243339,Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.,INCLUDE,Cellular signaling study
PMID:12393498,Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.,INCLUDE,Genetic interaction study
PMID:12469121,Nf1 has an essential role in endothelial cells.,INCLUDE,Animal model of endothelial function
PMID:12471027,Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor.,INCLUDE,Protein characterization study
PMID:12557125,The constitutional t(17;22): another translocation mediated by palindromic AT-rich repeats.,EXCLUDE,Chromosomal translocation study
PMID:12612091,Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.,INCLUDE,Molecular interaction study
PMID:12673723,Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.,INCLUDE,Drug screening method
PMID:12679023,PDZ tandem of human syntenin: crystal structure and functional properties.,INCLUDE,Protein structural analysis
PMID:12730209,Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.,INCLUDE,Molecular signaling study
PMID:12815562,A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2.,EXCLUDE,Genetic mapping study
PMID:12896975,Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A.,INCLUDE,Protein interaction study
PMID:12904481,Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants.,INCLUDE,Developmental biology model
PMID:12946024,Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.,INCLUDE,Cellular adhesion study
PMID:1333265,Tumour suppressor genes.,EXCLUDE,Review article
PMID:1336057,Constitutional ring chromosomes and tumour suppressor genes.,EXCLUDE,Chromosomal study
PMID:1348093,Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1.,EXCLUDE,Diagnostic technique review
PMID:1348095,Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus.,EXCLUDE,Genetic linkage study
PMID:1358802,The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene.,EXCLUDE,Genetic mapping study
PMID:1362425,Oncogene and growth factor expression in MEN 2 and related tumors.,EXCLUDE,Oncogene description
PMID:1362901,The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.,INCLUDE,Molecular interaction study
PMID:13679291,Orbit deformities in craniofacial neurofibromatosis type 1.,EXCLUDE,Clinical description
PMID:1376554,Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.,EXCLUDE,Immunolocalization description
PMID:1376775,SAG: a Schwann cell membrane glycoprotein.,EXCLUDE,Protein description
PMID:1414843,Gd-DTPA enhancement of the cisternal portion of the oculomotor nerve on MR imaging.,EXCLUDE,Diagnostic imaging description
PMID:1427886,A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.,INCLUDE,Genetic mapping reagent
PMID:14523097,The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.,INCLUDE,Signaling pathway research tool
PMID:14580336,"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.",INCLUDE,Protein interaction research tool
PMID:146075,Tumours of the cauda equina.,EXCLUDE,Clinical case description
PMID:14627667,Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.,INCLUDE,Comparative genomic hybridization method
PMID:14679174,It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.,INCLUDE,Cell interaction research model
PMID:14679180,Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.,INCLUDE,Cell signaling research model
PMID:14679203,Merlin neutralizes the inhibitory effect of Mdm2 on p53.,INCLUDE,Protein interaction research tool
PMID:14681409,The Unified Medical Language System (UMLS): integrating biomedical terminology.,INCLUDE,Computational terminology tool
PMID:14724565,Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.,INCLUDE,Cell migration research model
PMID:14740320,Mutations within the MGC4607 gene cause cerebral cavernous malformations.,EXCLUDE,Genetic mutation description
PMID:14741381,"PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.",INCLUDE,Protein modification research tool
PMID:1496981,Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.,INCLUDE,Chromosome deletion analysis
PMID:1496982,Neurofibromatosis type 2 appears to be a genetically homogeneous disease.,EXCLUDE,Genetic characterization review
PMID:14988005,Neurofibromin is actively transported to the nucleus.,INCLUDE,Protein localization research tool
PMID:14991710,Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.,INCLUDE,Animal model development
PMID:15039234,Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.,INCLUDE,Gene expression research tool
PMID:1505963,NF1-related locus on chromosome 15.,EXCLUDE,Genetic locus description
PMID:15123692,"Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.",INCLUDE,Protein interaction research tool
PMID:1519665,Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.,INCLUDE,In situ hybridization method
PMID:15206577,Gene expression analysis of the lung following paraquat administration in rats using DNA microarray.,INCLUDE,Gene expression microarray tool
PMID:15240917,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,INCLUDE,Patient-derived xenograft model
PMID:15255999,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",INCLUDE,Molecular profiling method
PMID:15286864,[Puberty and growth in children and adolescents with neuro fibromatosis type 1].,EXCLUDE,Clinical observation
PMID:15446585,Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.,INCLUDE,Gene expression profiling method
PMID:15520408,Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).,EXCLUDE,Clinical description
PMID:15570216,Targeted gene expression in the chicken eye by in ovo electroporation.,INCLUDE,Gene expression targeting method
PMID:15598747,Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.,INCLUDE,Protein interaction research tool
PMID:15623944,DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.,INCLUDE,Chromosome analysis method
PMID:15645067,[Learning and memory].,EXCLUDE,Cognitive review
PMID:15647118,Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.,INCLUDE,Clinical assessment tool
PMID:15652750,Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.,INCLUDE,Molecular pathway research tool
PMID:15659388,Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.,INCLUDE,Protein interaction research tool
PMID:15681480,Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.,INCLUDE,Genetic deletion detection method
PMID:15712001,Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.,EXCLUDE,Clinical treatment description
PMID:15767669,TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.,INCLUDE,Gene transcription research tool
PMID:15831594,Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.,INCLUDE,Longitudinal growth measurement tool
PMID:15832546,Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.,INCLUDE,Clinical assessment tool
PMID:15840687,NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.,INCLUDE,Genetic mutation analysis
PMID:15849434,Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.,INCLUDE,Protein interaction research tool
PMID:1587809,Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue.,INCLUDE,Protein expression method
PMID:15926055,Proliferation potential of spinal meningiomas.,EXCLUDE,Tumor proliferation observation
PMID:15937108,The NF1 tumor suppressor critically regulates TSC2 and mTOR.,INCLUDE,Molecular signaling research tool
PMID:1596091,Recent progress toward understanding the molecular biology of von Recklinghausen neurofibromatosis.,EXCLUDE,Review article
PMID:15988004,Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.,INCLUDE,Transcriptional regulation research tool
PMID:15994874,The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.,EXCLUDE,Genetic mutation description
PMID:16033085,Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.,INCLUDE,Genetic mutation analysis method
PMID:16036108,Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.,INCLUDE,Transcription factor research tool
PMID:1605307,Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.,INCLUDE,Transgenic animal model
PMID:16061561,Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.,INCLUDE,Mutation analysis method
PMID:16082189,Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance.,INCLUDE,Drug screening method
PMID:16093333,Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.,INCLUDE,Animal model research tool
PMID:16098465,Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.,INCLUDE,Genetic interaction research tool
PMID:16116616,Palindromic AT-rich repeat in the NF1 gene is hypervariable in humans and evolutionarily conserved in primates.,INCLUDE,Genetic sequence analysis method
PMID:16117786,Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1.,INCLUDE,Genetic mutation analysis
PMID:16169856,The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.,INCLUDE,Molecular pathway research tool
PMID:16173828,CyberKnife Frameless Radiosurgery for the treatment of extracranial benign tumors.,EXCLUDE,Surgical technique description
PMID:16226702,A mouse model for studying therapy-induced cancers.,INCLUDE,Animal model development
PMID:16226708,Therapy-induced malignant neoplasms in Nf1 mutant mice.,INCLUDE,Animal model development
PMID:16242402,PDF receptor signaling in Drosophila contributes to both circadian and geotactic behaviors.,EXCLUDE,Behavioral research description
PMID:16267393,The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.,INCLUDE,Protein modification research tool
PMID:16276382,[Hereditary endocrine tumour diseases].,EXCLUDE,Clinical review
PMID:16287988,Ras-related signaling pathways in valve development: ebb and flow.,EXCLUDE,Developmental biology review
PMID:16314489,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,INCLUDE,Animal model research tool
PMID:16324214,"Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.",INCLUDE,Evolutionary genetics method
PMID:16340004,New approaches to the analysis of palindromic sequences from the human genome: evolution and polymorphism of an intronic site at the NF1 locus.,INCLUDE,Genetic sequence analysis method
PMID:1636515,Spinal MR findings in neurofibromatosis types 1 and 2.,EXCLUDE,Diagnostic imaging description
PMID:16374483,Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes.,INCLUDE,Protein interaction research tool
PMID:16380919,NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.,EXCLUDE,Genetic mutation description
PMID:1639394,A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene.,INCLUDE,Genetic mapping reagent
PMID:16397625,A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.,INCLUDE,Protein interaction research tool
PMID:16406348,Immune system evasion by peripheral nerve sheath tumor.,EXCLUDE,Immunology observation
PMID:16418572,Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice.,INCLUDE,Drug screening method
PMID:16438728,Sperm protein 17 is expressed in human nervous system tumours.,EXCLUDE,Protein expression observation
PMID:16482197,CafÃ©-au-lait patches and senile plaques: How APPt the connection?,EXCLUDE,Genetic association review
PMID:16513807,Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.,INCLUDE,Molecular pathway research tool
PMID:16524466,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,INCLUDE,Animal model research tool
PMID:16537381,Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.,INCLUDE,Protein interaction research tool
PMID:16571745,Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells.,INCLUDE,Cell interaction research tool
PMID:16581517,The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.,INCLUDE,Protein interaction research tool
PMID:16613742,[Treatment of congenital pseudarthrosis of tibia by vascularized fibular graft].,EXCLUDE,Surgical technique description
PMID:16619545,Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.,INCLUDE,Molecular expression analysis method
PMID:16642646,Neurofibromatosis.,EXCLUDE,Review article
PMID:1672744,A polymorphic cDNA probe on chromosome 17q11.2 located within the NF1 gene [D17S376].,INCLUDE,Genetic mapping reagent
PMID:16786042,A prospective study of neurofibromatosis type 1 cancer incidence in the UK.,EXCLUDE,Epidemiological study
PMID:16793550,The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.,INCLUDE,Molecular pathway research tool
PMID:16795074,"Imaging, morphologic, and immunohistochemical correlation in gastrointestinal stromal tumors.",EXCLUDE,Imaging description
PMID:1679535,A TaqI polymorphism in the human NF1 gene.,INCLUDE,Genetic polymorphism method
PMID:1679929,A BglII polymorphism in the human NF1 gene.,INCLUDE,Genetic polymorphism method
PMID:16835260,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,INCLUDE,Cell interaction research model
PMID:1684425,A BglII RFLP near the human neurofibromatosis type 1 (NF1) gene.,INCLUDE,Genetic polymorphism method
PMID:16870183,NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region.,INCLUDE,mRNA biogenesis research tool
PMID:16894610,Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.,INCLUDE,Gene expression research tool
PMID:16906226,The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.,INCLUDE,Animal model research tool
PMID:1696266,Angiogenic and invasive properties of neurofibroma Schwann cells.,EXCLUDE,Cell characteristic description
PMID:16996265,The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size.,EXCLUDE,Developmental biology review
PMID:17053831,Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.,INCLUDE,Animal model research tool
PMID:17075701,Electrophysiological validation of a human prototype auditory midbrain implant in a guinea pig model.,INCLUDE,Animal model research tool
PMID:17090653,Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.,INCLUDE,Animal model research tool
PMID:17141624,Protein nutrition as therapy for a genetic disorder of bone?,EXCLUDE,Theoretical nutritional therapy
PMID:17149968,Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor).,EXCLUDE,Tumor pathology description
PMID:1715669,The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin.,INCLUDE,Cell origin research method
PMID:17157787,A negative feedback signaling network underlies oncogene-induced senescence.,EXCLUDE,Signaling network review
PMID:17167629,Extreme lateral approach to ventral and ventrolaterally situated lesions of the lower brainstem and upper cervical cord.,EXCLUDE,Surgical approach description
PMID:17171142,Advantages of the retrosigmoid approach in auditory brain stem implantation.,EXCLUDE,Surgical technique description
PMID:17171155,Atypical invasion of the temporal bone in vestibular schwannoma.,EXCLUDE,Tumor invasion description
PMID:17202204,Refractive errors in neurofibromatosis type 1 and type 2.,EXCLUDE,Clinical observation
PMID:17210637,"Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.",INCLUDE,Protein interaction characterization
PMID:17215387,Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves.,INCLUDE,Genetic signaling pathway analysis
PMID:17216419,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,INCLUDE,Genetic strain background analysis
PMID:17220301,The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes.,EXCLUDE,Molecular signaling mechanism
PMID:17295913,Functional analysis of splicing mutations in exon 7 of NF1 gene.,INCLUDE,Genetic splicing mutation analysis
PMID:17297447,HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.,EXCLUDE,Protein interaction description
PMID:17297459,Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.,EXCLUDE,Tumor microenvironment review
PMID:1729894,Multicolor in situ hybridization and linkage analysis order Charcot-Marie-Tooth type I (CMTIA) gene-region markers.,INCLUDE,Genetic linkage analysis method
PMID:17387725,Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.,EXCLUDE,Clinical review
PMID:17453145,How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?,EXCLUDE,Biochemical mechanism review
PMID:17548515,Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.,INCLUDE,Molecular signaling pathway research
PMID:17558420,Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.,INCLUDE,Drug screening method
PMID:17581973,Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.,INCLUDE,Memory formation genetic research
PMID:17636453,Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.,EXCLUDE,Genetic counseling recommendations
PMID:17649826,Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.,INCLUDE,Receptor expression analysis
PMID:17661042,[Cytologic diagnosis of soft tissue tumors].,EXCLUDE,Cytologic diagnostic description
PMID:17666887,The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1.,EXCLUDE,Diagnostic criteria description
PMID:17684762,Hereditary neuroendocrine tumors of the gastroenteropancreatic system.,EXCLUDE,Tumor type review
PMID:1770531,Watson syndrome: is it a subtype of type 1 neurofibromatosis?,EXCLUDE,Syndrome classification
PMID:17786186,MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.,INCLUDE,Tumor progression molecular analysis
PMID:1783401,cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.,INCLUDE,Genetic sequencing method
PMID:17848560,Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiation.,EXCLUDE,Cellular differentiation mechanism
PMID:17868749,Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.,INCLUDE,Genetic mutation characterization
PMID:17924978,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,INCLUDE,Animal model development
PMID:17962031,Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.,INCLUDE,Cell culture model system
PMID:17971776,Nf2/Merlin: a coordinator of receptor signalling and intercellular contact.,EXCLUDE,Signaling mechanism review
PMID:18055911,Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.,INCLUDE,Genetic deletion detection method
PMID:18057212,Electrical stimulation of the midbrain for hearing restoration: insight into the functional organization of the human central auditory system.,EXCLUDE,Surgical technique description
PMID:1810882,Lisch spots in neurofibromatosis type 1.,EXCLUDE,Clinical observation
PMID:18164492,Auditory brainstem implants.,EXCLUDE,Surgical technique description
PMID:18186933,The role of Drosophila Merlin in spermatogenesis.,EXCLUDE,Genetic mechanism description
PMID:18188004,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,INCLUDE,Gene expression analysis method
PMID:18218617,"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.",INCLUDE,Cellular differentiation research
PMID:18242512,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,INCLUDE,Cellular proliferation model
PMID:18242513,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,INCLUDE,Stem cell research method
PMID:18272679,Neurofibromin is required for barrel formation in the mouse somatosensory cortex.,INCLUDE,Animal model research
PMID:18289904,Generalized metabolic bone disease in Neurofibromatosis type I.,EXCLUDE,Clinical observation
PMID:18323865,Advances in the molecular biology of malignant mesothelioma.,EXCLUDE,Review article
PMID:18328429,A conditional mouse model for malignant mesothelioma.,INCLUDE,Animal model development
PMID:18350738,Sonographic features of soft tissue tumors in the hand and forearm.,EXCLUDE,Imaging technique description
PMID:18367665,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,INCLUDE,Drug screening method
PMID:18371380,Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.,INCLUDE,Cellular differentiation research
PMID:18400577,"Syndromes, disorders and maternal risk factors associated with neural tube defects (II).",EXCLUDE,Clinical risk factor review
PMID:18413802,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,INCLUDE,Drug screening method
PMID:18442999,Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.,INCLUDE,Animal model research
PMID:18445079,Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.,INCLUDE,Cellular signaling research
PMID:18446851,"Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations.",EXCLUDE,Genetic mutation description
PMID:18451155,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,INCLUDE,Animal model research
PMID:18483311,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,INCLUDE,Drug screening method
PMID:18490122,Plasticity and injury in the developing brain.,EXCLUDE,Neuroplasticity review
PMID:18503770,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,INCLUDE,Genetic splicing analysis
PMID:18563507,Osteosarcoma development and stem cell differentiation.,EXCLUDE,Developmental biology review
PMID:18592002,"RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.",EXCLUDE,Genetic mutation description
PMID:18596174,Neurotrophin-dependent dendritic filopodial motility: a convergence on PI3K signaling.,EXCLUDE,Molecular signaling mechanism
PMID:18614544,Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.,INCLUDE,Physiological regulation research
PMID:18632543,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,INCLUDE,Clinical assessment tool
PMID:18632626,Merlin is a potent inhibitor of glioma growth.,INCLUDE,Tumor growth inhibition research
PMID:18636037,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,INCLUDE,Xenograft model development
PMID:18669204,[Skin and its main neurocristopathies].,EXCLUDE,Clinical description
PMID:18670322,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,INCLUDE,Molecular expression analysis
PMID:18671247,Genetic aberrations of gastrointestinal stromal tumors.,EXCLUDE,Genetic mutation description
PMID:18671844,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,INCLUDE,Animal model research
PMID:18725676,V osteotomy and Ilizarov technique for residual idiopathic or neurogenic clubfeet.,EXCLUDE,Surgical technique description
PMID:1875943,trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene.,EXCLUDE,Transgenic mechanism description
PMID:18768391,Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.,INCLUDE,Cellular signaling research
PMID:18769552,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,INCLUDE,Molecular expression analysis
PMID:18781192,Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.,EXCLUDE,Genetic mutation description
PMID:18796406,Class III beta-tubulin is a component of the mitotic spindle in multiple cell types.,EXCLUDE,Cellular mechanism description
PMID:18800150,Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.,INCLUDE,Genetic mutation analysis
PMID:18803326,How does the Schwann cell lineage form tumors in NF1?,EXCLUDE,Cellular mechanism review
PMID:1883874,"sar1, a gene from Schizosaccharomyces pombe encoding a protein that regulates ras1.",EXCLUDE,Genetic mechanism description
PMID:18923024,Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.,INCLUDE,Cellular interaction research
PMID:18927496,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,INCLUDE,Drug screening method
PMID:18931645,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,INCLUDE,Xenograft imaging model
PMID:18952585,Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.,EXCLUDE,Clinical review
PMID:18953429,"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.",INCLUDE,Cellular signaling research
PMID:18953430,Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.,INCLUDE,Animal model research
PMID:18958364,Neurofibromatosis: the role of guanosine triphosphatase activating proteins in sensory neuron function.,EXCLUDE,Molecular mechanism review
PMID:18974932,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,INCLUDE,Molecular pathway research
PMID:18976311,Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders.,EXCLUDE,Clinical observation
PMID:18984150,It takes a (dysfunctional) village to raise a tumor.,EXCLUDE,Theoretical review
PMID:18984156,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,INCLUDE,Animal model research
PMID:18984165,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,INCLUDE,Molecular signaling research
PMID:18988803,Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.,INCLUDE,Drug screening method
PMID:1899288,The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene.,EXCLUDE,Genetic sequence description
PMID:19016857,Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1.,INCLUDE,Genetic splicing analysis
PMID:1903357,"cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene.",EXCLUDE,Genetic sequence description
PMID:1903395,Characterization of a GTPase-activating protein for the Ras-related Ral protein.,EXCLUDE,Molecular mechanism description
PMID:19041782,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,INCLUDE,Cellular progenitor research
PMID:19043547,A PI3-kinase-mediated negative feedback regulates neuronal excitability.,EXCLUDE,Molecular signaling mechanism
PMID:1905930,"Purification and N-terminal sequence of the p21rho GTPase-activating protein, rho GAP.",EXCLUDE,Protein purification description
PMID:19076779,Only in congenial soil: the microenvironment in brain tumorigenesis.,EXCLUDE,Theoretical review
PMID:19103750,"The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.",INCLUDE,Protein interaction research tool
PMID:19144871,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,INCLUDE,Protein binding partner identification
PMID:1915269,The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid.,INCLUDE,Enzymatic activity research method
PMID:19164945,Pediatric low-grade gliomas and the need for new options for therapy: Why and how?,EXCLUDE,Review article on therapy
PMID:1918456,Skin and bones. I.,EXCLUDE,Unspecified clinical description
PMID:1918486,Skin and bones. II.,EXCLUDE,Unspecified clinical description
PMID:19191334,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,INCLUDE,Microarray analysis tool
PMID:1922042,Overexpression of transforming growth factor-beta in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene.,EXCLUDE,Transgenic animal model description
PMID:19240363,Muscular force is reduced in neurofibromatosis type 1.,EXCLUDE,Clinical observation
PMID:19245780,[Surgical treatment of vagal paragangliomas].,EXCLUDE,Surgical procedure description
PMID:19262146,Phosphorylation of merlin regulates its stability and tumor suppressive activity.,INCLUDE,Protein modification research method
PMID:19282654,"Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1.",INCLUDE,Cell culture experimental method
PMID:19292874,Low U1 snRNP dependence at the NF1 exon 29 donor splice site.,INCLUDE,Genetic splice site analysis
PMID:19306381,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,INCLUDE,Cell migration research method
PMID:19333415,Drosophila melanogaster as a model organism of brain diseases.,INCLUDE,Drosophila disease model
PMID:19360115,Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours.,EXCLUDE,Clinical survival analysis
PMID:19380279,Neurofibromatosis.,EXCLUDE,General review
PMID:19414599,Ral overactivation in malignant peripheral nerve sheath tumors.,INCLUDE,Molecular signaling research method
PMID:19427284,The neurofibroma cell of origin: SKPs expand the playing field.,INCLUDE,Cell of origin research tool
PMID:19427294,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,INCLUDE,Cell origin and microenvironment model
PMID:19430883,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,INCLUDE,Clinical response criteria development
PMID:19434310,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,INCLUDE,Immunohistochemical diagnostic tool
PMID:19451225,"NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.",INCLUDE,Molecular signaling pathway research
PMID:1946460,Identification and characterization of the neurofibromatosis type 1 protein product.,INCLUDE,Protein characterization method
PMID:19470767,Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.,INCLUDE,Drug resistance research method
PMID:19476995,Neurofibromatosis type 2.,EXCLUDE,Clinical review
PMID:19479903,Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.,INCLUDE,Protein interaction research
PMID:19487675,Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma.,INCLUDE,Animal model of disease
PMID:19539839,Neurofibromatosis type 1.,EXCLUDE,Clinical review
PMID:19568883,Molecular biology of malignant mesothelioma.,EXCLUDE,Review article
PMID:19574548,Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.,INCLUDE,Genetic knockout model
PMID:19610677,Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects.,INCLUDE,Enzymatic mechanism research
PMID:19621444,Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.,INCLUDE,Quality of life assessment tool
PMID:19652604,"Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].",EXCLUDE,Clinical review
PMID:19690597,[Neurofibromatosis type 2 and auditory brainstem implantation].,EXCLUDE,Clinical procedure description
PMID:19703993,Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.,INCLUDE,Molecular signaling research
PMID:19710506,Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.,INCLUDE,Genetic mouse model
PMID:1972563,Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q.,EXCLUDE,Genetic mapping description
PMID:19750304,[Neurofibromatosis type 1: more frequent and severe then usually thought].,EXCLUDE,Clinical review
PMID:19789989,Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cells.,INCLUDE,Cell culture experimental method
PMID:19793348,Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells.,INCLUDE,Genomic analysis method
PMID:19794125,Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.,INCLUDE,Genetic mutation analysis
PMID:19846776,PTEN dosage is essential for neurofibroma development and malignant transformation.,INCLUDE,Genetic dosage research model
PMID:19877719,Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.,INCLUDE,Protein profiling method
PMID:19884346,Fluorescence resonance energy transfer analysis of merlin conformational changes.,INCLUDE,Protein conformational analysis tool
PMID:19901965,Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.,INCLUDE,Molecular targeting research
PMID:19919001,"Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome.",EXCLUDE,Clinical longitudinal study
PMID:19966217,Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.,INCLUDE,Zebrafish disease model
PMID:1999496,"Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro.",INCLUDE,Cell expression analysis method
PMID:20002172,Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.,INCLUDE,Molecular mechanism research
PMID:20049721,Neurofibromatosis and lessons for the war on cancer.,EXCLUDE,Review article
PMID:20049725,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,INCLUDE,Genomic analysis method
PMID:20054405,"Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene product.",INCLUDE,Protein interaction research
PMID:20065362,Outcome of osteoplastic laminotomy for excision of spinal cord tumours.,EXCLUDE,Surgical procedure description
PMID:20150373,Inherited predisposition to glioma.,EXCLUDE,Review article
PMID:20154721,NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.,INCLUDE,Molecular signaling research
PMID:20156804,Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.,INCLUDE,Protein overexpression method
PMID:20159598,Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded.,INCLUDE,Molecular signaling pathway research
PMID:20160012,The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.,INCLUDE,Protein regulation research
PMID:20160346,Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.,INCLUDE,Genetic and cellular research method
PMID:20165677,Spinal loop rectangle and sub laminar wiring as a technique for scoliosis correction.,EXCLUDE,Surgical technique description
PMID:20176786,Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis.,INCLUDE,Bioluminescent imaging model
PMID:20181838,"The tumor suppressor merlin is required for cell cycle exit, terminal differentiation, and cell polarity in the developing murine lens.",INCLUDE,Genetic knockout model
PMID:20187887,"Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.",INCLUDE,Clinical assessment tool
PMID:20195187,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,INCLUDE,Cell culture knockdown method
PMID:20200958,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,INCLUDE,Genetic disease model
PMID:20209053,Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice.,INCLUDE,Molecular signaling research
PMID:20212043,Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation.,INCLUDE,Molecular signaling pathway research
PMID:2022740,Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.,EXCLUDE,Genetic analysis description
PMID:20233966,Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.,INCLUDE,Chromosome engineering method
PMID:20233971,Mast cells and the neurofibroma microenvironment.,INCLUDE,Microenvironment research model
PMID:20302846,"Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.",INCLUDE,Drug discovery research method
PMID:20345245,Molecular and cellular mechanisms of learning disabilities: a focus on NF1.,INCLUDE,Molecular mechanism research
PMID:20368450,Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants.,INCLUDE,Protein transport research method
PMID:20388501,Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake.,INCLUDE,Genome-wide expression analysis
PMID:20406973,Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.,INCLUDE,Therapeutic approach research
PMID:20410111,Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.,INCLUDE,Molecular mechanism research
PMID:20428190,NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1.,INCLUDE,Clinical prediction tool
PMID:20431046,Ras and Rap signaling in synaptic plasticity and mental disorders.,INCLUDE,Molecular signaling research
PMID:20483692,Neuronal activity evoked in the inferior colliculus of the cat by surface macroelectrodes and penetrating microelectrodes implanted in the cochlear nucleus.,EXCLUDE,Neurophysiological recording method
PMID:20491622,"Merlin, a ""magic"" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.",INCLUDE,Molecular signaling research
PMID:20511180,ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.,INCLUDE,Preclinical drug efficacy research
PMID:20530151,"Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.",EXCLUDE,Clinical case description
PMID:20550523,MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.,INCLUDE,MicroRNA regulation research
PMID:20551058,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,INCLUDE,Genetic disease model
PMID:20554030,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,INCLUDE,Molecular mechanism research
PMID:20571392,Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.,INCLUDE,Genetic disease model
PMID:20600672,Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.,INCLUDE,Ultrastructural imaging model
PMID:20605257,Phenotypic variability among cafÃ©-au-lait macules in neurofibromatosis type 1.,EXCLUDE,Clinical phenotype description
PMID:20606732,CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.,INCLUDE,Immunohistochemical analysis method
PMID:20624961,Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.,INCLUDE,Neurological function research
PMID:20643348,The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.,INCLUDE,Molecular signaling pathway research
PMID:20643380,Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.,EXCLUDE,Review article
PMID:20667203,Diagnosis and endovascular treatment of vertebral arteriovenous fistulas in neurofibromatosis type 1.,EXCLUDE,Clinical procedure description
PMID:20668197,A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory.,INCLUDE,Drosophila disease model
PMID:20668201,Merlin inhibits neurite outgrowth in the CNS.,INCLUDE,Molecular mechanism research
PMID:20670070,Multiple non-metastatic gastrointestinal stromal tumors. Differential features.,EXCLUDE,Clinical case description
PMID:20680410,The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.,INCLUDE,Molecular signaling research
PMID:20686603,The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.,INCLUDE,Molecular analysis method
PMID:20694012,Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.,EXCLUDE,Genetic mutation description
PMID:20699653,Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.,INCLUDE,Patient-derived xenograft model
PMID:20711205,Cutaneous features predict paraspinal neurofibromas in neurofibromatosis type 1.,EXCLUDE,Clinical feature description
PMID:20736812,Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.,EXCLUDE,Clinical treatment report
PMID:20739432,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,INCLUDE,Gene expression biomarker identification
PMID:20814256,Emerging pharmacotherapies for neurodevelopmental disorders.,EXCLUDE,Pharmacotherapy review
PMID:20816579,Hereditary genodermatoses with cancer predisposition.,EXCLUDE,Genetic syndrome review
PMID:20818339,MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.,INCLUDE,MicroRNA expression profiling
PMID:20821343,Epidemiology and etiology of meningioma.,EXCLUDE,Epidemiological review
PMID:20826448,Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.,INCLUDE,Animal model research
PMID:20833335,"Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.",EXCLUDE,Endocrine tumor review
PMID:20856158,MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.,INCLUDE,Molecular mechanism study
PMID:20858602,Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene.,INCLUDE,Zebrafish genetic model
PMID:20890305,Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.,INCLUDE,Molecular signaling mechanism
PMID:20920304,"Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma.",INCLUDE,Computational gene expression analysis
PMID:20951236,"Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.",INCLUDE,Clinical trial participant experience tool
PMID:20951316,Solid tumors associated with multiple endocrine neoplasias.,EXCLUDE,Tumor syndrome review
PMID:21031597,Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.,INCLUDE,Genetic loss of heterozygosity analysis
PMID:21051559,Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.,EXCLUDE,Metabolomic phenotype description
PMID:210531,Intrathoracic neural tumours.,EXCLUDE,Tumor location review
PMID:2105641,Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.,INCLUDE,Genetic marker identification
PMID:21072183,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,INCLUDE,Cell transformation model
PMID:21074722,"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.",INCLUDE,Molecular mechanism study
PMID:21084862,Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).,INCLUDE,Molecular mechanism study
PMID:21090964,Toward fulfilling the promise of molecular medicine in fragile X syndrome.,EXCLUDE,Syndrome review
PMID:21111000,A novel imaging-compatible sciatic nerve schwannoma model.,INCLUDE,Animal model development
PMID:21139978,"HuB/C/D, nPTB, REST4, and miR-124 regulators of neuronal cell identity are also utilized in the lens.",EXCLUDE,Molecular biology review
PMID:21147885,Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.,EXCLUDE,Clinical diagnosis description
PMID:21152085,Which neurodevelopmental disorders get researched and why?,EXCLUDE,Research priority review
PMID:21153564,Health-related quality of life in preschool children in five health conditions.,EXCLUDE,Quality of life survey
PMID:21157378,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,INCLUDE,Animal model research
PMID:21173220,Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.,EXCLUDE,Genetic mutation description
PMID:21173843,Do PAKs make good drug targets?,EXCLUDE,Drug target review
PMID:2117565,The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations.,INCLUDE,Genetic mapping
PMID:21182951,Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.,INCLUDE,Molecular mechanism study
PMID:2119504,Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.,INCLUDE,Genetic mapping
PMID:21196210,Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors.,INCLUDE,Genetic basis of tumorigenesis
PMID:21199799,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,INCLUDE,Animal model research
PMID:2121371,The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.,INCLUDE,Genetic mechanism study
PMID:21216928,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,INCLUDE,Animal model research
PMID:21224727,Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy.,INCLUDE,Drug mechanism study
PMID:21255467,SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.,INCLUDE,Genetic mutation analysis
PMID:21263951,Neurofibromatosis.,EXCLUDE,General review
PMID:21272240,"Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes.",EXCLUDE,Surgical procedure review
PMID:21281783,The development of cutaneous neurofibromas.,EXCLUDE,Clinical feature description
PMID:21307646,Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.,EXCLUDE,Therapeutic review
PMID:21347399,"Neurofibromatosis type 1 and the ""elephant man's"" disease: the confusion persists: an ethnographic study.",EXCLUDE,Ethnographic study
PMID:21352477,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,INCLUDE,Animal model research
PMID:21358191,Hereditary paragangliomas.,EXCLUDE,Genetic syndrome review
PMID:21383154,Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.,INCLUDE,Molecular mechanism study
PMID:21402777,FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.,INCLUDE,Molecular mechanism study
PMID:2142531,Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.,INCLUDE,Genetic mutation analysis
PMID:21439034,Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).,EXCLUDE,Mortality epidemiology
PMID:21439418,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,INCLUDE,Animal model research
PMID:21451418,Empirical development of improved diagnostic criteria for neurofibromatosis 2.,INCLUDE,Clinical diagnostic criteria development
PMID:21454924,"miRNA signature of schwannomas: possible role(s) of ""tumor suppressor"" miRNAs in benign tumors.",INCLUDE,MicroRNA signature study
PMID:21455202,"Adrenal cortical tumors, pheochromocytomas and paragangliomas.",EXCLUDE,Tumor type review
PMID:21460792,Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents.,INCLUDE,Patient-derived xenograft model
PMID:21465658,Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.,INCLUDE,Cellular function analysis
PMID:21478499,Neurofibromin (Nf1) is required for skeletal muscle development.,INCLUDE,Genetic mechanism study
PMID:21479127,Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.,INCLUDE,Molecular expression analysis
PMID:21487440,Multiplex ligation-depending probe amplification is not suitable for detection of low-grade mosaicism.,INCLUDE,Genetic testing method
PMID:21495177,Observations on intelligence and behavior in 15 patients with Legius syndrome.,EXCLUDE,Clinical observation study
PMID:21551250,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,INCLUDE,Cellular developmental model
PMID:21563229,Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.,INCLUDE,Genetic transcript analysis
PMID:21596366,Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.,INCLUDE,Molecular mechanism study
PMID:21621428,Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.,EXCLUDE,Clinical observation study
PMID:21636709,Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies.,INCLUDE,Molecular signaling mechanism
PMID:21659924,"ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.",INCLUDE,Molecular mechanism study
PMID:21666496,Comparative characterization of the human and mouse third ventricle germinal zones.,EXCLUDE,Comparative anatomy study
PMID:2167436,"Evi-2, a common integration site involved in murine myeloid leukemogenesis.",INCLUDE,Genetic integration site study
PMID:21681782,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,INCLUDE,Animal model research
PMID:21686274,Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.,INCLUDE,Molecular mechanism study
PMID:21694737,Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.,EXCLUDE,Mortality epidemiology
PMID:21697395,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,INCLUDE,Drug discovery screening
PMID:21726432,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,INCLUDE,Biomarker identification
PMID:21727212,Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.,INCLUDE,Drug candidate study
PMID:21732786,Emergence of a high-grade sarcoma in a recurrent meningioma: malignant progression or collision tumor?,EXCLUDE,Case report
PMID:21748792,Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.,INCLUDE,Cellular mechanism study
PMID:21750658,Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.,INCLUDE,Molecular mechanism study
PMID:21750756,Solitary penile neurofibroma with erectile dysfunction.,EXCLUDE,Case report
PMID:21778190,"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.",INCLUDE,Drug mechanism study
PMID:21822956,Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?,EXCLUDE,Clinical feature description
PMID:21832260,Genetic architecture of declarative memory: implications for complex illnesses.,EXCLUDE,Genetic architecture review
PMID:21855613,Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.,INCLUDE,Animal model research
PMID:21876680,A comprehensive map of mobile element insertion polymorphisms in humans.,INCLUDE,Genetic mapping
PMID:21878642,KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1.,INCLUDE,Molecular mechanism study
PMID:21892375,Autism and metabolic cytopathy.,EXCLUDE,Clinical observation study
PMID:21896734,Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.,INCLUDE,Molecular mechanism study
PMID:21903164,Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.,INCLUDE,Molecular mechanism study
PMID:21921333,The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors.,EXCLUDE,Diagnostic imaging review
PMID:21931722,The probable cell of origin of NF1- and PDGF-driven glioblastomas.,INCLUDE,Cell origin study
PMID:21949590,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,INCLUDE,Animal model research
PMID:21949657,The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.,INCLUDE,Genetic mechanism study
PMID:21961044,Erk1 positively regulates osteoclast differentiation and bone resorptive activity.,INCLUDE,Cellular mechanism study
PMID:21963267,Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.,INCLUDE,Diagnostic imaging method
PMID:21963652,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,INCLUDE,Animal model imaging method
PMID:21980365,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,INCLUDE,Animal model research
PMID:21996526,Congenital pseudarthrosis of the tibia.,EXCLUDE,Clinical condition description
PMID:22012890,"Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.",INCLUDE,Molecular mechanism study
PMID:22069171,Histopathology of gastrointestinal stromal tumor.,EXCLUDE,Pathology review
PMID:22077553,Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.,INCLUDE,Plexiform neurofibroma cell/stromal interaction model
PMID:22105166,Another VCP interactor: NF is enough.,EXCLUDE,Protein interaction description
PMID:22105171,Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.,EXCLUDE,Protein interaction mechanism
PMID:22108604,Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.,INCLUDE,Somatic mutation genetic screening
PMID:22118770,SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.,EXCLUDE,Protein degradation mechanism
PMID:22125493,The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion.,INCLUDE,Genetic mutation analysis tool
PMID:22155606,Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.,EXCLUDE,Mutational spectrum review
PMID:22160322,Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.,EXCLUDE,Molecular mechanism review
PMID:22247700,Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/Î²-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways.,EXCLUDE,Signaling pathway analysis
PMID:22250039,Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.,EXCLUDE,Chromosomal recombination mechanism
PMID:22325036,Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.,EXCLUDE,Protein structure analysis
PMID:22355270,Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.,EXCLUDE,Chromosomal instability description
PMID:22384355,The SPRED1 Variants Repository for Legius Syndrome.,INCLUDE,Genetic variant repository
PMID:22407831,Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.,EXCLUDE,Potential therapeutic target
PMID:22426462,Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.,EXCLUDE,Signaling pathway regulation
PMID:22429592,Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.,EXCLUDE,Genetic background review
PMID:22431917,Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.,EXCLUDE,Signaling mechanism description
PMID:22433254,Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1.,EXCLUDE,Pharmacological intervention study
PMID:22449146,From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation.,EXCLUDE,Protein interaction mechanism
PMID:22466437,Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.,EXCLUDE,Potential therapeutic approach
PMID:22479462,Cross-species analyses identify the BNIP-2 and Cdc42GAP homology (BCH) domain as a distinct functional subclass of the CRAL_TRIO/Sec14 superfamily.,EXCLUDE,Protein domain analysis
PMID:22488919,Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?,EXCLUDE,Genetic mechanism investigation
PMID:22491145,"The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423.",EXCLUDE,Potential drug mechanism
PMID:22493273,Neurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extension.,INCLUDE,Drosophila animal model
PMID:22493760,Oncologic manifestations of neurofibromatosis type 1 in Korea.,EXCLUDE,Oncologic manifestation review
PMID:22495656,Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines.,EXCLUDE,Potential drug mechanism
PMID:22503123,Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.,EXCLUDE,Clinical tumor progression study
PMID:22525268,"The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.",EXCLUDE,Protein trafficking mechanism
PMID:22526161,MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4).,EXCLUDE,MicroRNA correlation study
PMID:22550514,Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.,INCLUDE,Cell culture model development
PMID:22555179,Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression.,EXCLUDE,Genetic characterization
PMID:22578218,Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.,EXCLUDE,Potential therapeutic target review
PMID:22595235,"Merlin, a multi-suppressor from cell membrane to the nucleus.",EXCLUDE,Protein function review
PMID:22619737,Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders.,EXCLUDE,Synaptic plasticity mechanism
PMID:22654338,Plexiform neurofibroma of the submandibular salivary gland: a rare tumour.,EXCLUDE,Case report
PMID:22691888,Pheochromocytoma: implications in tumorigenesis and the actual management.,EXCLUDE,Tumor review
PMID:22718995,MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors.,EXCLUDE,MicroRNA regulation study
PMID:22723888,Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network.,EXCLUDE,Brain activation study
PMID:22742554,Differentiating neurotized melanocytic nevi from neurofibromas using Melan-A (MART-1) immunohistochemical stain.,EXCLUDE,Diagnostic technique description
PMID:22750751,Merlin: the wizard requires protein stability to function as a tumor suppressor.,EXCLUDE,Protein function mechanism
PMID:2277079,Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein.,EXCLUDE,Gene structure description
PMID:22776759,Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.,INCLUDE,Computational drug discovery tool
PMID:22778675,Perioperative management of neurofibromatosis type 1.,EXCLUDE,Clinical management review
PMID:22798089,Pulmonary arterial hypertension associated with neurofibromatosis type 1.,EXCLUDE,Clinical condition description
PMID:22798428,Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.,EXCLUDE,Signaling pathway mechanism
PMID:22811580,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,INCLUDE,Transcriptome analysis tool
PMID:22821631,The plexiform neurofibroma microenvironment.,EXCLUDE,Tumor microenvironment description
PMID:22821737,The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.,INCLUDE,Research network development
PMID:22825583,New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.,EXCLUDE,Potential therapeutic targets review
PMID:22858714,Radiographic association of schwannomas with sensory ganglia.,EXCLUDE,Radiographic association study
PMID:22881119,The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.,EXCLUDE,Cognitive impact study
PMID:22891239,Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.,EXCLUDE,Potential therapeutic approach
PMID:22901811,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,INCLUDE,Neural progenitor cell model
PMID:22912849,Merlin is a negative regulator of human melanoma growth.,EXCLUDE,Tumor suppressor mechanism
PMID:22916147,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,INCLUDE,Molecular genetic analysis tool
PMID:22918238,Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFÎ² signaling and defects in the Hippo signaling cascade.,EXCLUDE,Signaling pathway mechanism
PMID:22931905,Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.,EXCLUDE,Drug development review
PMID:22942771,Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.,INCLUDE,Secretome analysis method
PMID:22943010,Molecular pathology of pancreatic neuroendocrine tumors.,EXCLUDE,Molecular pathology review
PMID:22945628,Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis.,EXCLUDE,Molecular mechanism description
PMID:22949158,Jelly Belly trans-synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture.,EXCLUDE,Synaptic signaling mechanism
PMID:22961690,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,INCLUDE,Clinical trial methodology
PMID:22980241,"Pattern of skin diseases at university of Benin teaching hospital, Benin city, Edo State, South-South Nigeria: a 12 month prospective study.",EXCLUDE,Epidemiological study
PMID:23045281,Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.,INCLUDE,Schwann cell tumor model
PMID:23055477,Neurofibromatosis type 1: modeling CNS dysfunction.,INCLUDE,CNS dysfunction modeling
PMID:23056445,Neurofibromin 1 is a miRNA target in neurons.,EXCLUDE,MicroRNA target mechanism
PMID:23056937,"Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1.",INCLUDE,Clinical assessment tool
PMID:23066466,Genitourinary plexiform neurofibroma mimicking sacrococcygeal teratoma.,EXCLUDE,Case report
PMID:23071067,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,INCLUDE,Animal tumor model
PMID:23073669,Temporal processing in the auditory system: insights from cochlear and auditory midbrain implantees.,EXCLUDE,Auditory processing study
PMID:23082153,Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways.,EXCLUDE,Molecular pathway mechanism
PMID:23087000,Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.,INCLUDE,Oncogenic transformation model
PMID:23099891,Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.,EXCLUDE,Tumor microenvironment study
PMID:23108260,A-Z of malignant peripheral nerve sheath tumors.,EXCLUDE,Tumor type review
PMID:23124644,Anatomic MR imaging and functional diffusion tensor imaging of peripheral nerve tumors and tumorlike conditions.,INCLUDE,Imaging analysis method
PMID:23139750,Impaired Pten expression in human malignant peripheral nerve sheath tumours.,EXCLUDE,Tumor characterization
PMID:23140466,Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.,INCLUDE,Viral vector gene therapy approach
PMID:23144792,c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.,EXCLUDE,Cellular signaling mechanism
PMID:23151902,"Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.",EXCLUDE,Drug mechanism study
PMID:23158014,An emerging role for microRNAs in NF1 tumorigenesis.,EXCLUDE,MicroRNA review
PMID:23163236,Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.,EXCLUDE,Psychiatric comorbidity study
PMID:23175151,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,INCLUDE,MicroRNA profiling method
PMID:23175848,Neurofibromin mediates FAK signaling in confining synapse growth at Drosophila neuromuscular junctions.,EXCLUDE,Molecular interaction mechanism
PMID:23185366,The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.,EXCLUDE,Molecular signaling mechanism
PMID:23197650,Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.,EXCLUDE,Cellular pathway study
PMID:23205330,Carbon dioxide laser treatment of cutaneous neurofibromas.,EXCLUDE,Treatment technique description
PMID:23205844,"Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.",EXCLUDE,Comorbidity relationship study
PMID:23213372,Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with Î²1 integrin and actin at the plasma membrane.,EXCLUDE,Protein interaction mechanism
PMID:23221337,Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.,INCLUDE,Animal disease model
PMID:23221339,Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.,EXCLUDE,Cellular signaling mechanism
PMID:23221341,MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.,EXCLUDE,Drug efficacy study
PMID:23225063,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,INCLUDE,Animal behavioral model
PMID:23229624,Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.,EXCLUDE,Behavioral study
PMID:23239957,LEOPARD Syndrome: Clinical Features and Gene Mutations.,EXCLUDE,Clinical genetic description
PMID:23239959,Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.,INCLUDE,Cell culture mechanosensory model
PMID:23244685,Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.,EXCLUDE,Molecular characterization
PMID:23267122,"Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.",EXCLUDE,Protein function review
PMID:23268719,Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth.,EXCLUDE,Potential drug mechanism
PMID:23295772,Optic pathway gliomas in adolescence--time to challenge treatment choices?,EXCLUDE,Clinical treatment review
PMID:23308224,"Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma.",EXCLUDE,Protein interaction mechanism
PMID:23312374,Modeling cognitive dysfunction in neurofibromatosis-1.,INCLUDE,Animal model for cognitive dysfunction
PMID:23318430,EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.,INCLUDE,Signaling pathway research
PMID:23325962,Congenital pseudarthrosis of the tibia: Management and complications.,EXCLUDE,Clinical management description
PMID:23328114,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,INCLUDE,Genomic analysis method
PMID:23348505,"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.",INCLUDE,Genomic mutation analysis
PMID:23356716,Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma.,INCLUDE,Confocal microscopy imaging tool
PMID:23358504,Integrated proteomics identified novel activation of dynein IC2-GR-COX-1 signaling in neurofibromatosis type I (NF1) disease model cells.,INCLUDE,Proteomics research method
PMID:23362481,Radiofrequency ablation and excision of multiple cutaneous lesions in neurofibromatosis type 1.,EXCLUDE,Clinical procedure description
PMID:23406822,"Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.",EXCLUDE,Neuroimaging observation
PMID:23412344,Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.,INCLUDE,Tumor model research
PMID:23413263,Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.,INCLUDE,Cell line characterization
PMID:23423222,RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.,INCLUDE,Gene expression analysis
PMID:23424002,Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.,INCLUDE,Animal model research
PMID:23431398,Predicting future morphological changes of lesions from radiotracer uptake in 18F-FDG-PET images.,EXCLUDE,Imaging prediction study
PMID:23432799,"Development of the adult PedsQLâ¢ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",INCLUDE,Clinical assessment tool development
PMID:23434321,CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.,INCLUDE,Molecular signaling research
PMID:23446537,"[Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].",INCLUDE,Quality of life assessment tool
PMID:23450503,Proteus: Mythology to modern times.,EXCLUDE,Review article
PMID:23457139,Genetic aspects of pheochromocytoma.,EXCLUDE,Genetic review
PMID:23457304,Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.,INCLUDE,Cell line signaling research
PMID:23475878,An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance.,INCLUDE,Genetic interaction research
PMID:23487764,NMR-based functional profiling of RASopathies and oncogenic RAS mutations.,INCLUDE,NMR functional profiling method
PMID:23524941,"PAK1-deficiency/down-regulation reduces brood size, activates HSP16.2 gene and extends lifespan in Caenorhabditis elegans.",INCLUDE,Genetic screening method
PMID:23535903,"Canonical Wnt/Î²-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",INCLUDE,Cell transformation research
PMID:23555837,Genetic interactions between neurofibromin and endothelin receptor B in mice.,INCLUDE,Genetic interaction animal model
PMID:23567558,The FBW7-KLF2 axis regulates endothelial functions.,EXCLUDE,Molecular pathway review
PMID:23583712,Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.,INCLUDE,Protein interaction research
PMID:23598837,Neurofibromatosis: types 1 and 2.,EXCLUDE,Review article
PMID:23666797,"Merlin, the NF2 gene product.",EXCLUDE,Review article
PMID:23669226,Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.,EXCLUDE,Review article
PMID:23672502,Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration.,EXCLUDE,Review article
PMID:23682341,The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas.,EXCLUDE,Clinical treatment review
PMID:23685747,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,INCLUDE,Genetic screening method
PMID:23702730,Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.,EXCLUDE,Clinical observation
PMID:23714726,Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.,INCLUDE,Drug target research
PMID:23723300,Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.,INCLUDE,Genotype-specific metabolic analysis
PMID:23749527,Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors.,INCLUDE,Molecular pathway research
PMID:23762458,Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.,INCLUDE,Animal behavioral model
PMID:23776757,Natural history of multiple meningiomas.,EXCLUDE,Clinical observation
PMID:23848554,MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.,INCLUDE,MicroRNA profiling method
PMID:23853621,A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1.,EXCLUDE,Clinical case report
PMID:23858101,NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.,INCLUDE,Genetic deletion model
PMID:23863460,Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.,INCLUDE,Animal model research
PMID:23863479,Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.,INCLUDE,Animal model research
PMID:23875798,The RASopathies.,EXCLUDE,Review article
PMID:23891030,Imaging of the non-traumatic brachial plexus.,EXCLUDE,Clinical imaging review
PMID:23907387,An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.,INCLUDE,Genomic characterization method
PMID:23928514,Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide.,INCLUDE,Compound screening research
PMID:23934191,LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.,INCLUDE,Potential therapeutic target research
PMID:23934881,Rare variants in hypermutable genes underlie common morphology and growth traits in wild Saccharomyces paradoxus.,EXCLUDE,Genetic variation study
PMID:23935382,Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.,EXCLUDE,Epidemiological observation
PMID:23940289,Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.,EXCLUDE,Molecular pathway review
PMID:23948079,Polyadenylation site-specific differences in the activity of the neuronal Î²CstF-64 protein in PC-12 cells.,EXCLUDE,Molecular mechanism study
PMID:23960073,"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.",INCLUDE,Small molecule inhibitor research
PMID:24012335,Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.,INCLUDE,Molecular signaling research
PMID:24035394,Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.,INCLUDE,Animal model research
PMID:24040940,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,INCLUDE,Drug resistance research method
PMID:24065580,Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.,INCLUDE,Clinical assessment tool
PMID:24082600,"Synchronous tricompartmental benign CNS tumors with tonsillar herniation, cervicodorsal syringomyelia and hydrocephalus.",EXCLUDE,Clinical case report
PMID:24101678,Autism traits in the RASopathies.,INCLUDE,Clinical assessment tool
PMID:24101736,Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1.,EXCLUDE,Clinical imaging study
PMID:24132643,EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.,INCLUDE,Molecular pathway research
PMID:24133387,Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management.,EXCLUDE,Clinical imaging review
PMID:24189137,Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.,INCLUDE,Metabolic marker research
PMID:24197987,Vision specific quality of life in children with optic pathway gliomas.,INCLUDE,Quality of life assessment tool
PMID:24205087,Transcriptome analysis of Nautilus and pygmy squid developing eye provides insights in lens and eye evolution.,EXCLUDE,Evolutionary biology study
PMID:24211110,Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.,INCLUDE,Animal model research
PMID:24213576,PPARÎ²/Î´ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.,INCLUDE,Molecular pathway research
PMID:24216989,Lost in translation: ambiguity in nerve sheath tumor nomenclature and its resultant treatment effect.,EXCLUDE,Nomenclature review
PMID:24232507,Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.,INCLUDE,Animal model research
PMID:24249801,Achieving consensus for clinical trials: the REiNS International Collaboration.,INCLUDE,Clinical trial consensus method
PMID:24249802,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,INCLUDE,Clinical outcome measure development
PMID:24249804,Recommendations for imaging tumor response in neurofibromatosis clinical trials.,INCLUDE,Imaging response assessment tool
PMID:24249805,Conclusions and future directions for the REiNS International Collaboration.,EXCLUDE,Review article
PMID:24249806,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,INCLUDE,Patient-reported outcome tool
PMID:24259290,Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.,INCLUDE,Molecular mechanism research
PMID:24261697,High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.,INCLUDE,Molecular mutation analysis
PMID:24285727,Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.,INCLUDE,Preclinical therapeutic research
PMID:24294527,Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins.,EXCLUDE,Review article
PMID:24295733,Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders.,INCLUDE,Animal behavioral model
PMID:24297905,Regulation of Son of sevenless by the membrane-actin linker protein ezrin.,INCLUDE,Molecular interaction research
PMID:24309211,Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.,INCLUDE,Molecular signaling research
PMID:24335216,Primary auditory cortical responses to electrical stimulation of the thalamus.,EXCLUDE,Neurophysiology study
PMID:24336571,Genome-scale CRISPR-Cas9 knockout screening in human cells.,INCLUDE,CRISPR screening method
PMID:24346802,"Evaluation of Bcl-2, Bcl-x and cleaved caspase-3 in malignant peripheral nerve sheath tumors and neurofibromas.",INCLUDE,Molecular marker research
PMID:24371224,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,INCLUDE,Molecular pathway research
PMID:24375753,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,INCLUDE,Animal model research
PMID:24386979,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",INCLUDE,Molecular signaling research
PMID:24414536,mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.,INCLUDE,Drug target research
PMID:24426510,"""Huge axillary mass - neurofibroma brachial plexus"".",EXCLUDE,Clinical case report
PMID:24431436,Neurofibromin is the major ras inactivator in dendritic spines.,INCLUDE,Molecular mechanism research
PMID:24443661,Compounds from ,EXCLUDE,Incomplete title
PMID:24450866,Schwannomas and their pathogenesis.,EXCLUDE,Review article
PMID:24465906,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",INCLUDE,Bone pathology research
PMID:24470552,Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.,INCLUDE,Viral therapy research
PMID:24500418,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",INCLUDE,Clinical drug trial
PMID:24503545,Expression of WW domain-containing oxidoreductase WOX1 in human nervous system tumors.,INCLUDE,Molecular expression research
PMID:24506781,Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.,INCLUDE,Genetic therapy method
PMID:24509877,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,INCLUDE,Molecular pathway research
PMID:24551382,Using image references in radiology reports to support enhanced report-to-image navigation.,EXCLUDE,Radiology reporting method
PMID:24558021,Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.,INCLUDE,Proteomic screening method
PMID:24559228,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,INCLUDE,Neurophysiological assessment tool
PMID:2456020,Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors.,INCLUDE,Immunohistochemical method
PMID:24582430,[Neurofibromatosis type 2 and its head and neck manifestations: literature review and population study in the Community of Cantabria and the province of Las Palmas].,EXCLUDE,Clinical review
PMID:24585726,Transposable elements and psychiatric disorders.,EXCLUDE,Theoretical review
PMID:24595234,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,INCLUDE,In vivo functional analysis method
PMID:24596649,Gouty tophi.,EXCLUDE,Clinical description
PMID:24603440,"The rate of nonallelic homologous recombination in males is highly variable, correlated between monozygotic twins and independent of age.",EXCLUDE,Genetic inheritance study
PMID:24619350,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,INCLUDE,Quality of life assessment tool
PMID:24676424,Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.,INCLUDE,Genetic sequencing method
PMID:24676443,Neurofibromatoses: part 1 - diagnosis and differential diagnosis.,EXCLUDE,Diagnostic review
PMID:24681606,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,INCLUDE,Genetically engineered mouse model
PMID:24686726,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,INCLUDE,Zebrafish animal model
PMID:24711647,ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome.,INCLUDE,Candidate gene research
PMID:24719295,Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice.,INCLUDE,Animal model with intervention
PMID:24726726,Molecular insights into NF2/Merlin tumor suppressor function.,INCLUDE,Molecular insights method
PMID:24753394,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,INCLUDE,Clinical trial with intervention
PMID:24786638,Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.,INCLUDE,Molecular analysis method
PMID:24815379,Application of COLD-PCR for improved detection of NF2 mosaic mutations.,INCLUDE,Mutation detection technique
PMID:24817309,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,INCLUDE,Neural progenitor research method
PMID:24824755,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,INCLUDE,Cell death screening method
PMID:24832557,Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.,INCLUDE,Genetic modification model
PMID:24848258,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,INCLUDE,Molecular sensitivity screening
PMID:24862762,NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.,EXCLUDE,Cellular mechanism study
PMID:24882693,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,INCLUDE,Protein structural analysis
PMID:24891857,Ventrally located cervical dumbbell ganglioneuroma producing spinal cord compression.,EXCLUDE,Clinical case report
PMID:24912773,Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.,INCLUDE,Molecular interaction analysis
PMID:2491775,Genetic analysis of eight loci tightly linked to neurofibromatosis 1.,INCLUDE,Genetic linkage mapping
PMID:2491777,Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.,INCLUDE,Genetic mapping technique
PMID:2491778,Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1).,INCLUDE,Genetic marker research
PMID:2491779,A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.,INCLUDE,Genetic mapping method
PMID:2491781,Close flanking markers for neurofibromatosis type I (NF1).,INCLUDE,Genetic marker technique
PMID:2491782,"Linkage analysis of neurofibromatosis type I, using chromosome 17 DNA markers.",INCLUDE,Linkage analysis method
PMID:2491783,Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.,INCLUDE,Physical mapping technique
PMID:2491784,Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.,INCLUDE,Multipoint linkage analysis
PMID:2491785,"The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints.",INCLUDE,Chromosome mapping method
PMID:24925884,Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.,INCLUDE,Immunohistochemical marker study
PMID:24932921,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,INCLUDE,Transcriptional dysregulation analysis
PMID:24936445,Role of Hyaluronic Acid Treatment in the Prevention ofÂ Keloid Scarring.,EXCLUDE,Treatment review
PMID:24958239,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,INCLUDE,Genomic mutation analysis
PMID:24975854,Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1.,EXCLUDE,Personalized medicine perspective
PMID:24980480,Novel age-dependent targets in vestibular schwannomas.,INCLUDE,Age-dependent target identification
PMID:24997609,"Asfotase-Î± improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",INCLUDE,Animal model intervention
PMID:25003081,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,INCLUDE,Integrative genomic analysis
PMID:2500456,"Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures.",INCLUDE,Cell culture method
PMID:25012216,A neuronal function of the tumor suppressor protein merlin.,INCLUDE,Neuronal function analysis
PMID:25026211,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,INCLUDE,Molecular pathway analysis
PMID:25026295,The NF1 gene revisited - from bench to bedside.,EXCLUDE,Review article
PMID:25030515,Neurofibromatosis type 1: a multidisciplinary approach to care.,EXCLUDE,Clinical care review
PMID:25043298,Oncogenic role of Merlin/NF2 in glioblastoma.,INCLUDE,Oncogenic mechanism study
PMID:25043591,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,INCLUDE,Animal model intervention
PMID:2506682,Progress towards identifying the neurofibromatosis (NF1) gene.,EXCLUDE,Research progress review
PMID:25070947,Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.,INCLUDE,Molecular signaling analysis
PMID:25074460,Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?,INCLUDE,Next-generation sequencing method
PMID:25079666,Primary culture of human vestibular schwannomas.,INCLUDE,Primary cell culture technique
PMID:25083141,Insights into synaptic function from mouse models of human cognitive disorders.,INCLUDE,Mouse model research
PMID:25092287,Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.,INCLUDE,Biological target identification
PMID:25109740,TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.,INCLUDE,Gene expression analysis
PMID:25113746,A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.,INCLUDE,Murine disease model
PMID:25120781,Vascular alterations in schwannoma.,EXCLUDE,Vascular description
PMID:2512777,High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.,EXCLUDE,Imaging description
PMID:2516405,[Von Recklinghausen's neurofibromatosis].,EXCLUDE,Clinical review
PMID:25169151,SWI/SNF chromatin remodeling complexes and cancer.,EXCLUDE,Review article
PMID:25184332,Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.,INCLUDE,Animal pain model
PMID:25204795,Regulation of cell proliferation and adhesion by means of a novel region of drosophila merlin interacting with Sip1.,INCLUDE,Protein interaction analysis
PMID:25217104,The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.,INCLUDE,Molecular pathway analysis
PMID:25240281,PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.,INCLUDE,Genetic mutation analysis
PMID:25243094,Using the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.,EXCLUDE,Developmental biology review
PMID:25246427,The impact of coexisting genetic mutations on murine optic glioma biology.,INCLUDE,Genetic interaction study
PMID:25274808,Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knock-out mice.,INCLUDE,Animal behavioral model
PMID:25289889,Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.,INCLUDE,Combination therapy screening
PMID:2531845,Mutations in the p53 gene occur in diverse human tumour types.,EXCLUDE,Mutation survey
PMID:25325900,The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.,INCLUDE,Genetic sequencing validation
PMID:25329635,Genetic modifiers of neurofibromatosis type 1-associated cafÃ©-au-lait macule count identified using multi-platform analysis.,INCLUDE,Genetic modifier analysis
PMID:25335493,Expanding the mutational spectrum of LZTR1 in schwannomatosis.,INCLUDE,Mutation spectrum analysis
PMID:25336744,The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.,INCLUDE,Developmental animal model
PMID:25340526,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,INCLUDE,Drug screening method
PMID:25360213,A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.,INCLUDE,Chemical biology approach
PMID:25364327,Hydrocephalus following bilateral dumbbell-shaped c2 spinal neurofibromas resection and postoperative cervical pseudomeningocele in a patient with neurofibromatosis type 1: a case report.,EXCLUDE,Clinical case report
PMID:25377441,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,INCLUDE,Pain assessment tool development
PMID:25422459,Structure-guided U2AF65 variant improves recognition and splicing of a defective pre-mRNA.,EXCLUDE,Molecular mechanism study
PMID:25424184,Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1.,EXCLUDE,Clinical observation
PMID:25433207,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,INCLUDE,Developmental signaling analysis
PMID:25437141,Auditory brainstem implant: electrophysiologic responses and subject perception.,EXCLUDE,Clinical device assessment
PMID:25437375,"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.",INCLUDE,Neurophysiological analysis
PMID:25452392,Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.,INCLUDE,Tumor clonality analysis
PMID:25452937,Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,EXCLUDE,Treatment review
PMID:25475340,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,INCLUDE,Clinical measurement method
PMID:25480913,Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.,INCLUDE,Genetic mutation analysis
PMID:25483302,Regulation of vesicle transport and cell motility by Golgi-localized Dbs.,EXCLUDE,Cellular mechanism study
PMID:25483400,Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.,INCLUDE,Animal behavioral model
PMID:25490687,Neurofibromatosis-related tumors: emerging biology and therapies.,EXCLUDE,Research perspective
PMID:25492402,A hereditary disposition for bovine peripheral nerve sheath tumors in Danish Holstein cattle.,EXCLUDE,Veterinary observation
PMID:2551169,Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.,INCLUDE,Animal tumor model
PMID:25517743,NF GEMMs already! The power and promise of mouse tumor models.,EXCLUDE,Modeling perspective
PMID:25534182,Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.,INCLUDE,Quality of life assessment
PMID:25534823,Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.,INCLUDE,Molecular pathway inhibition
PMID:25535838,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,INCLUDE,Animal developmental model
PMID:25549701,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,INCLUDE,Exome sequencing method
PMID:25549703,"Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome.",EXCLUDE,Therapeutic review
PMID:25551830,Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.,INCLUDE,Potential biomarker development
PMID:25557241,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,INCLUDE,Preimplantation genetic diagnosis method
PMID:25596744,Group I Paks as therapeutic targets in NF2-deficient meningioma.,INCLUDE,Therapeutic target identification
PMID:25616962,FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.,INCLUDE,Genetic signaling mechanism
PMID:25621266,Oropharyngeal Dysphagia: neurogenic etiology and manifestation.,EXCLUDE,Clinical description
PMID:2562822,Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type I.,INCLUDE,Genetic mapping technique
PMID:25639352,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,INCLUDE,Animal model with genetic deletion
PMID:25657467,Emperor Ashoka: Did he suffer from von Recklinghausen's diseases?,EXCLUDE,Historical medical speculation
PMID:25692621,Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.,INCLUDE,Signaling pathway analysis
PMID:25710373,Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.,INCLUDE,Phylogenetic computational analysis
PMID:2573276,Refined physical and genetic mapping of the NF1 region on chromosome 17.,INCLUDE,Genetic mapping technique
PMID:25742877,"Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.",EXCLUDE,Clinical diagnostic review
PMID:25750037,Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects.,INCLUDE,Molecular pathway investigation
PMID:25772366,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,INCLUDE,Cancer stem cell model
PMID:25788518,Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.,INCLUDE,Genetic mutation functional analysis
PMID:25817485,[The tip of the iceberg: cutaneous manifestations of paediatric diseases with neurological involvement].,EXCLUDE,Clinical manifestation review
PMID:25823924,NF2 blocks Snail-mediated p53 suppression in mesothelioma.,INCLUDE,Molecular pathway mechanism
PMID:25833823,STAT3 and HIF1Î± Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Oncogenic signaling analysis
PMID:25851896,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,INCLUDE,Primary tissue culture method
PMID:25877069,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,INCLUDE,Cell line establishment
PMID:25877329,A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.,INCLUDE,Genetic mutation analysis
PMID:25884485,Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.,INCLUDE,Genetic copy number variation analysis
PMID:25887585,NMF-mGPU: non-negative matrix factorization on multi-GPU systems.,INCLUDE,Computational tool development
PMID:25893273,High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins.,INCLUDE,Imaging mass spectrometry technique
PMID:25893302,Role of Merlin/NF2 inactivation in tumor biology.,INCLUDE,Tumor suppressor mechanism
PMID:25902174,Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.,INCLUDE,Genetic mutation screening
PMID:25909290,Expression alterations define unique molecular characteristics of spinal ependymomas.,INCLUDE,Gene expression analysis
PMID:25917016,"Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.",INCLUDE,Animal model with genetic modification
PMID:25917366,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,INCLUDE,Potential therapeutic target identification
PMID:25933494,Nutrient intake in neurofibromatosis type 1: A cross-sectional study.,EXCLUDE,Nutritional cross-sectional study
PMID:25943106,Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome.,EXCLUDE,Treatment outcome report
PMID:25946318,Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.,INCLUDE,Molecular pathway analysis
PMID:25962619,"ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.",INCLUDE,Genetic locomotor signature in model organism
PMID:25963359,Auditory Rehabilitation in Rhesus Macaque Monkeys (Macaca mulatta) with Auditory Brainstem Implants.,EXCLUDE,Clinical rehabilitation description
PMID:25976979,"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.",EXCLUDE,Clinical quality of life study
PMID:25983466,Neurilemmoma of median nerve.,EXCLUDE,Clinical case report
PMID:25990002,Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population.,EXCLUDE,Clinical imaging study
PMID:25993155,Achievements and challenges of molecular targeted therapy in melanoma.,EXCLUDE,Therapeutic review
PMID:26000738,Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.,INCLUDE,Animal model with genetic modification
PMID:26032208,Skeletal muscle and motor deficits in Neurofibromatosis Type 1.,EXCLUDE,Clinical symptom description
PMID:26039236,Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.,INCLUDE,Cellular signaling mechanism
PMID:26045165,Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.,INCLUDE,Molecular pathway mechanism
PMID:26057084,Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.,INCLUDE,Cellular signaling analysis
PMID:26066488,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,INCLUDE,Genetic mutation detection method
PMID:26073082,Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.,INCLUDE,Genetic mechanism investigation
PMID:26073604,The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis.,INCLUDE,Genetic mutation analysis
PMID:26076063,NF1 Mutations Are Common in Desmoplastic Melanoma.,INCLUDE,Genetic mutation screening
PMID:26083891,Neurofibromatosis: part 2--clinical management.,EXCLUDE,Clinical management review
PMID:26104281,Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.,EXCLUDE,Clinical observation
PMID:26110128,"Tumor-suppressor Genes, Cell Cycle Regulatory Checkpoints, and the Skin.",EXCLUDE,Review article
PMID:2611193,Optic nerve glioma and the management of optic nerve tumours in the young.,EXCLUDE,Clinical management review
PMID:26150484,In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.,INCLUDE,In vitro cellular model
PMID:26180607,Moyamoya Syndrome: A Window of Moyamoya Disease.,EXCLUDE,Clinical syndrome description
PMID:26190969,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",INCLUDE,In vivo synaptic transmission model
PMID:26219339,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,INCLUDE,High-throughput kinase screening
PMID:26258444,Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.,INCLUDE,Molecular mechanism analysis
PMID:26344136,NF2/Merlin is required for the axial pattern formation in the Xenopus laevis embryo.,INCLUDE,Developmental biology model
PMID:26344771,Mutational Analysis of Ionizing Radiation Induced Neoplasms.,INCLUDE,Mutational analysis method
PMID:26423696,How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.,INCLUDE,Molecular targeting strategy
PMID:26425473,"Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma.",EXCLUDE,Diagnostic method review
PMID:26445504,Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency.,INCLUDE,Developmental biology model
PMID:26461061,"Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.",INCLUDE,Therapeutic target development
PMID:26468183,Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.,INCLUDE,Animal model of neurological condition
PMID:26473019,"Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.",EXCLUDE,Clinical neuroimaging study
PMID:26478990,A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.,INCLUDE,Diagnostic method development
PMID:26480909,Extracranial neurogenic tumors of the head and neck.,EXCLUDE,Clinical tumor description
PMID:26483553,NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.,INCLUDE,Molecular mechanism analysis
PMID:26490262,Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression.,INCLUDE,Protein localization mechanism
PMID:26509978,Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing.,INCLUDE,Genetic splicing analysis
PMID:26518678,Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging.,EXCLUDE,Imaging technique review
PMID:26519538,Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.,EXCLUDE,Clinical trial design
PMID:26530423,Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats.,INCLUDE,Animal model of oncogenesis
PMID:26536237,Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.,INCLUDE,Genetic behavioral model
PMID:26549023,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",INCLUDE,Potential therapeutic target identification
PMID:26554010,Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.,INCLUDE,Treatment efficacy model
PMID:26558359,A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro.,INCLUDE,Drug screening method
PMID:26585554,Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.,INCLUDE,Molecular diagnostic marker
PMID:26631381,Lower fasting blood glucose in neurofibromatosis type 1.,EXCLUDE,Clinical metabolic study
PMID:26633276,[Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)].,EXCLUDE,Diagnostic strategy review
PMID:26635368,"Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.",INCLUDE,Molecular interaction analysis
PMID:26645727,Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.,INCLUDE,Molecular diagnostic marker
PMID:26657314,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,INCLUDE,Cell line establishment
PMID:26658687,RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.,INCLUDE,RNAi delivery method
PMID:26664443,Painless Loss of Vision as The First Presentation of Undiagnosed Neurofibromatosis 1 in A Child.,EXCLUDE,Clinical case report
PMID:26666764,Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.,EXCLUDE,Epidemiological study
PMID:26717333,Neurofibromatosis type 1 and cardiac manifestations.,EXCLUDE,Clinical review
PMID:26740486,The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.,INCLUDE,Comparative genomics approach
PMID:26740548,Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.,INCLUDE,Cellular signaling mechanism
PMID:26752825,Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging.,EXCLUDE,Clinical imaging review
PMID:26753962,ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.,INCLUDE,Molecular mechanism analysis
PMID:26758488,Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.,EXCLUDE,Clinical case report
PMID:26773288,Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning.,EXCLUDE,Clinical neuropsychological study
PMID:26783591,"Is Participating in Psychological Research a Benefit, Burden, or Both for Medically Ill Youth and Their Caregivers?",EXCLUDE,Research participation study
PMID:26822862,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,INCLUDE,Computational modeling approach
PMID:26840085,Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.,INCLUDE,Drug mechanism investigation
PMID:26851632,"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.",EXCLUDE,Therapeutic review
PMID:26861207,Feedback activation of neurofibromin terminates growth factor-induced Ras activation.,INCLUDE,Molecular signaling mechanism
PMID:26881921,Peripheral Attentional Targets under Covert Attention Lead to Paradoxically Enhanced Alpha Desynchronization in Neurofibromatosis Type 1.,EXCLUDE,Clinical neurological study
PMID:26883872,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,INCLUDE,3D imaging mass spectrometry technique
PMID:26896440,Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.,INCLUDE,Behavioral genetic model
PMID:2689863,trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene.,EXCLUDE,No research tool description
PMID:26904939,Insertional Mutagenesis Identifies a STAT3/Arid1b/Î²-catenin Pathway Driving Neurofibroma Initiation.,INCLUDE,Animal model for neurofibroma initiation
PMID:26908603,NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.,INCLUDE,Genetic mutation analysis
PMID:27018750,Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.,EXCLUDE,Epidemiological risk factor study
PMID:27021207,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,INCLUDE,Clinical assessment tool (therapy feasibility)
PMID:27035165,"Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.",EXCLUDE,Retrospective clinical pattern analysis
PMID:27057895,Surgical Treatment of Dystrophic Spinal Curves Caused by Neurofibromatosis Type 1: A Retrospective Study of 26 Patients.,EXCLUDE,Surgical procedure description
PMID:27078850,Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.,INCLUDE,Whole exome sequencing method
PMID:27081657,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,INCLUDE,Clinical trial with intervention
PMID:27103823,Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway.,INCLUDE,Molecular pathway investigation
PMID:27122017,Surgically treated solitary giant gluteal and retroperitoneal neurofibroma: a case report.,EXCLUDE,Surgical case report
PMID:27159396,Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.,INCLUDE,Drug targeting method
PMID:27216189,YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.,INCLUDE,Molecular signaling pathway analysis
PMID:27236105,RASopathy Gene Mutations in Melanoma.,EXCLUDE,Genetic mutation review
PMID:27236462,The importance of nerve microenvironment for schwannoma development.,EXCLUDE,Descriptive research
PMID:27263935,Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas.,EXCLUDE,Comparative clinical study
PMID:27269372,Contextual signaling in cancer.,EXCLUDE,Theoretical signaling review
PMID:27285107,Merlin inhibits Wnt/Î²-catenin signaling by blocking LRP6 phosphorylation.,INCLUDE,Molecular signaling mechanism
PMID:27313208,The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.,INCLUDE,Protein interaction research
PMID:27314079,"Intersections at the crossroads: Neurofibromatosis type 1, cAMP, sex, and glioma risk.",EXCLUDE,Descriptive risk analysis
PMID:27345717,"Merlin, a regulator of Hippo signaling, regulates Wnt/Î²-catenin signaling.",INCLUDE,Molecular signaling mechanism
PMID:27363027,Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.,INCLUDE,Drug inhibition method
PMID:27385209,"Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.",INCLUDE,Computational analysis tool
PMID:27418650,Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.,INCLUDE,Animal model development
PMID:27437341,Histopathological and Radiographic Analysis of Dental Follicle of Impacted Teeth Using Modified Gallego's Stain.,EXCLUDE,Histological staining technique
PMID:27441070,"Rare Malignancies in Eastern India, Socio-Economic Impact.",EXCLUDE,Epidemiological study
PMID:27458360,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,INCLUDE,Genetic polymorphism analysis
PMID:27467574,Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.,INCLUDE,Genetic deletion animal model
PMID:27508196,Emerging role of Hpo signaling and YAP in hepatocellular carcinoma.,EXCLUDE,Signaling pathway review
PMID:27516813,Sex bias in autism spectrum disorder in neurofibromatosis type 1.,EXCLUDE,Epidemiological observation
PMID:27517146,The role of nerve microenvironment for neurofibroma development.,EXCLUDE,Descriptive research
PMID:27527646,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,INCLUDE,Clinical trial outcome recommendation
PMID:27527648,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,INCLUDE,Patient-reported outcome tool
PMID:27551454,Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms.,INCLUDE,Molecular mechanism investigation
PMID:27588404,Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.,INCLUDE,Immunohistochemical analysis
PMID:27639957,[Neuropsychological performance in neurofibromatosis type 1].,EXCLUDE,Neuropsychological description
PMID:27655679,Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.,INCLUDE,Tissue microarray analysis
PMID:27706810,"Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.",INCLUDE,Drug targeting method
PMID:27708104,High-resolution interrogation of functional elements in the noncoding genome.,EXCLUDE,Genomic analysis review
PMID:27741517,"Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.",INCLUDE,Molecular mechanism investigation
PMID:27748759,EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.,INCLUDE,Molecular signaling pathway
PMID:27755359,Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.,INCLUDE,Drug targeting method
PMID:27760236,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,INCLUDE,Clinical assessment of autism
PMID:27773571,NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.,INCLUDE,Molecular interaction research
PMID:27791021,Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.,INCLUDE,Protein interaction research
PMID:27815398,Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.,INCLUDE,Clinical imaging analysis
PMID:27817916,Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.,INCLUDE,Clinical care recommendations
PMID:27833160,Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,INCLUDE,Drug combination method
PMID:27856782,Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.,INCLUDE,Diagnostic criteria refinement
PMID:27867327,Unusual Glomus Tumor of the Penis.,EXCLUDE,Case report
PMID:27874161,Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results.,EXCLUDE,Imaging technique description
PMID:27889578,Molecular neurobiology of mTOR.,EXCLUDE,Molecular review
PMID:27913619,The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.,INCLUDE,Genetic interaction research
PMID:27920939,Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.,INCLUDE,Epigenetic mechanism investigation
PMID:27921248,"The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.",INCLUDE,Molecular pathogenesis research
PMID:27923908,Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.,INCLUDE,Molecular mechanism investigation
PMID:27927008,MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.,INCLUDE,Molecular pathway research
PMID:27943006,Hereditary syndromes predisposing to endocrine tumors and their skin manifestations.,EXCLUDE,Syndrome review
PMID:27956228,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,INCLUDE,CRISPR screening method
PMID:27956565,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,INCLUDE,Clinical trial
PMID:27999334,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,INCLUDE,Genetic sequencing method
PMID:28001089,The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.,INCLUDE,Immune system analysis
PMID:28003305,"Co-occurring Mutations of Tumor Suppressor Genes, ",EXCLUDE,Mutation description
PMID:28029918,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,INCLUDE,Clinical drug trial
PMID:28039362,Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.,INCLUDE,Animal model time course
PMID:28051113,"A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.",INCLUDE,Genetic panel design
PMID:28052036,Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.,EXCLUDE,Molecular pathway description
PMID:28065690,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,INCLUDE,Drug screening method
PMID:28066715,Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.,INCLUDE,Drug discovery challenges
PMID:28067315,KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.,INCLUDE,Molecular mechanism research
PMID:28067895,The NF1 gene in tumor syndromes and melanoma.,EXCLUDE,Gene review
PMID:28068329,The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.,INCLUDE,Molecular mechanism investigation
PMID:28099845,Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.,INCLUDE,Metabolic pathway research
PMID:28125156,Application of the laser diode with central wavelength 975Â nm for the therapy of neurofibroma and hemangiomas.,INCLUDE,Therapeutic technique
PMID:28126595,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,INCLUDE,Proteomics analysis
PMID:28138125,Face Transplant in an Advanced Neurofibromatosis Type 1 Patient.,EXCLUDE,Surgical case report
PMID:28166733,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,INCLUDE,Machine learning classifier
PMID:28191549,Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma.,INCLUDE,Drug combination method
PMID:28193237,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,INCLUDE,Quality of life assessment tool
PMID:28195122,Integrated genomic analyses of de novo pathways underlying atypical meningiomas.,INCLUDE,Genomic analysis method
PMID:28256556,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,INCLUDE,Inflammatory gene signature
PMID:28285878,Stem Cell Factor-Based Identification and Functional Properties of InÂ Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.,EXCLUDE,Stem cell characterization
PMID:28291216,[Intramedullary spinal cord tumors and neurofibromatosis].,EXCLUDE,Clinical description
PMID:2831318,Metabolic imaging of human extremity musculoskeletal tumors by PET.,EXCLUDE,Imaging technique
PMID:28349408,Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.,EXCLUDE,Clinical description
PMID:28367137,"Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.",EXCLUDE,Mechanism review
PMID:28380429,Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.,EXCLUDE,Molecular pathway description
PMID:28392281,Human stem cell modeling in neurofibromatosis type 1 (NF1).,INCLUDE,Stem cell modeling
PMID:28398289,A high-throughput molecular data resource for cutaneous neurofibromas.,INCLUDE,Molecular data resource
PMID:28423318,Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.,INCLUDE,Genetic deletion model
PMID:28425622,Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.,INCLUDE,Genetic deletion model
PMID:28427224,Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.,INCLUDE,Drug mechanism research
PMID:28429332,The effect of post-injection ,EXCLUDE,Incomplete title
PMID:28441508,CyberKnife for Treatment of Vestibular Schwannoma: A Meta-analysis.,EXCLUDE,Treatment meta-analysis
PMID:28454108,Telomere erosion in NF1 tumorigenesis.,INCLUDE,Molecular mechanism research
PMID:28468780,Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses ,INCLUDE,Drug combination method
PMID:28489286,Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.,INCLUDE,Molecular mechanism research
PMID:28502478,The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.,INCLUDE,Molecular mechanism research
PMID:28525381,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,INCLUDE,Cell origin investigation
PMID:28529006,Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.,INCLUDE,Genetic sequencing pipeline
PMID:28542306,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,INCLUDE,Gene signature development
PMID:28548933,KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.,INCLUDE,Genetic mutation characterization
PMID:28558025,Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.,INCLUDE,Drug therapy experimental method
PMID:28558180,Neural Tumors of the Orbit -- What Is New?,EXCLUDE,Review of neural tumors
PMID:28562548,Pedicle screw versus hybrid posterior instrumentation for dystrophic neurofibromatosis scoliosis.,EXCLUDE,Surgical technique description
PMID:28566755,Merlin is required for coordinating proliferation of two stem cell lineages in the Drosophila testis.,INCLUDE,Stem cell research method
PMID:28578364,Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.,EXCLUDE,Clinical case series
PMID:28580399,Does pamidronate enhance the osteogenesis in mesenchymal stem cells derived from fibrous hamartoma in congenital pseudarthrosis of the tibia?,INCLUDE,Stem cell experimental method
PMID:28581486,The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals.,EXCLUDE,Signaling pathway review
PMID:28589254,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,INCLUDE,Tumor characterization method
PMID:28595424,Animal models of meningiomas.,INCLUDE,Animal model development
PMID:28608929,High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.,INCLUDE,Animal model development
PMID:28610844,Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.,INCLUDE,Molecular mechanism screening
PMID:28637487,The NF1 somatic mutational landscape in sporadic human cancers.,INCLUDE,Mutational landscape analysis
PMID:28640700,CNS Tumors in Neurofibromatosis.,EXCLUDE,Clinical review
PMID:28644838,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",INCLUDE,Patient registry development
PMID:28658406,Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.,EXCLUDE,Clinical comparison
PMID:28694877,Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies.,EXCLUDE,Clinical phenotype review
PMID:28713678,Drug development against the hippo pathway in mesothelioma.,EXCLUDE,Drug development overview
PMID:28725547,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,INCLUDE,Neuroimaging research method
PMID:28729415,An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.,INCLUDE,Molecular mechanism research
PMID:28735371,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,INCLUDE,Clinical assessment tool
PMID:28753199,Erratum: Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,INCLUDE,Computational modeling method
PMID:28761511,Genetic associations of intracranial aneurysm formation and sub-arachnoid hemorrhage.,EXCLUDE,Genetic association study
PMID:28764788,Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.,INCLUDE,Molecular mechanism research
PMID:28776579,Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.,INCLUDE,Diagnostic marker research
PMID:28783719,Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.,INCLUDE,Drug sensitivity screening
PMID:28783725,A Braf kinase-inactive mutant induces lung adenocarcinoma.,INCLUDE,Animal model development
PMID:28789444,p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during ,INCLUDE,Molecular mechanism research
PMID:28813519,"Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.",INCLUDE,Gene expression analysis
PMID:28814319,Constipation in adults with neurofibromatosis type 1.,EXCLUDE,Clinical symptom description
PMID:28831766,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,INCLUDE,Protein structure research
PMID:2884037,Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.,EXCLUDE,Genetic linkage study
PMID:28846462,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,INCLUDE,Immunohistochemical marker development
PMID:28848060,Genetic Severity Score predicts clinical phenotype in NF2.,INCLUDE,Genetic severity scoring tool
PMID:28850815,Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research.,EXCLUDE,Review of research technologies
PMID:2889831,A genomic search for linkage of neurofibromatosis to RFLPs.,EXCLUDE,Genetic linkage study
PMID:28923059,Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.,INCLUDE,Molecular mechanism research
PMID:2896631,Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17.,EXCLUDE,Genetic linkage study
PMID:28972170,Î²1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.,INCLUDE,Molecular signaling mechanism
PMID:28993414,A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies.,EXCLUDE,Collaborative research overview
PMID:2902204,Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.,EXCLUDE,Imaging methodology
PMID:29032173,The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.,INCLUDE,Cellular mechanism research
PMID:29117388,Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.,EXCLUDE,Research agenda review
PMID:29118993,Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour.,EXCLUDE,Tumor cell characterization
PMID:29131833,MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.,INCLUDE,Drug sensitivity screening
PMID:29137242,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,INCLUDE,Immune profiling method
PMID:29139538,Limitations of the Pax7-creER,EXCLUDE,Methodology limitations discussion
PMID:2914791,Radiotherapy of soft tissue sarcomas in dogs.,EXCLUDE,Radiotherapy review
PMID:29179212,LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.,INCLUDE,Molecular mechanism research
PMID:29179472,"BCRP expression in schwannoma, plexiform neurofibroma and MPNST.",INCLUDE,Molecular marker research
PMID:29185159,"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 ",INCLUDE,Cellular mechanism research
PMID:29206885,Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?,INCLUDE,Metabolic characterization method
PMID:2921281,Perineurial cells coexpress genes encoding interstitial collagens and basement membrane zone components.,EXCLUDE,Cellular gene expression review
PMID:29246098,Optic Pathway Gliomas in Neurofibromatosis Type 1.,EXCLUDE,Clinical review
PMID:29249622,Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.,INCLUDE,Developmental biology mechanism
PMID:29257151,[Pathogenic alterations within the neurofibromin gene in various cancers].,EXCLUDE,Genetic mutation review
PMID:29290338,Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.,EXCLUDE,Genotype-phenotype correlation
PMID:29331035,Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study.,INCLUDE,Diagnostic imaging technique
PMID:29342057,Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.,EXCLUDE,Clinical natural history
PMID:29351992,Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis.,INCLUDE,Molecular mechanism research
PMID:29354122,Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.,INCLUDE,Immunological mechanism research
PMID:29372092,Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofibromatosis and a Factor V Leiden Mutation.,EXCLUDE,Clinical case report
PMID:29384852,Pain correlates with germline mutation in schwannomatosis.,EXCLUDE,Clinical pain correlation
PMID:29402968,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,INCLUDE,Diagnostic sequencing method
PMID:29408605,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,INCLUDE,Cellular mechanism research
PMID:29409008,"Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.",INCLUDE,Genetic diagnostic tool
PMID:29409029,The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.,INCLUDE,Tumor progression characterization
PMID:29415745,Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.,INCLUDE,Clinical quantitative assessment
PMID:29423604,Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).,INCLUDE,Clinical assessment tool
PMID:29426343,Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition.,INCLUDE,Molecular mechanism research
PMID:29440379,Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.,INCLUDE,Drug sensitivity screening
PMID:29441367,Molecular characterization and pathogenesis of gastrointestinal stromal tumor.,EXCLUDE,Molecular characterization review
PMID:29493886,Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.,INCLUDE,Molecular mechanism research
PMID:29515781,CXCR4: A new player in vestibular schwannoma pathogenesis.,INCLUDE,Molecular mechanism research
PMID:29555977,Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.,EXCLUDE,Molecular mechanism review
PMID:29566645,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",INCLUDE,Neuroimaging research method
PMID:29570943,"The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1.",INCLUDE,Clinical assessment tool
PMID:29587439,NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.,INCLUDE,Molecular mechanism research
PMID:29588991,Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in ,EXCLUDE,Clinical case report
PMID:29590612,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,INCLUDE,Molecular mechanism research
PMID:29596064,Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.,INCLUDE,Tumor microenvironment research
PMID:29626191,Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.,INCLUDE,Molecular mechanism research
PMID:29629523,Attention Deficit Hyperactivity Disorder in Neurofibromatosis Type 1: Evaluation with a Continuous Performance Test.,INCLUDE,Clinical assessment tool
PMID:29649040,Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.,EXCLUDE,Clinical treatment outcome
PMID:29659143,RASopathies are associated with a distinct personality profile.,EXCLUDE,Clinical phenotype description
PMID:29662612,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,INCLUDE,Metabolic mechanism research
PMID:29666462,Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.,INCLUDE,Drug mechanism research
PMID:29667529,Emerging therapeutic targets for neurofibromatosis type 1.,EXCLUDE,Therapeutic targets review
PMID:29670214,Restoring functional neurofibromin by protein transduction.,INCLUDE,Protein restoration method
PMID:29670726,"Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1.",EXCLUDE,Clinical dental characteristics
PMID:29692918,Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.,EXCLUDE,Clinical treatment evaluation
PMID:29704429,Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.,INCLUDE,Animal model research
PMID:29712669,Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis.,INCLUDE,Molecular mechanism research
PMID:29715273,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,INCLUDE,Cellular mechanism research
PMID:29718344,Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.,INCLUDE,Clinical progression assessment
PMID:29731861,Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells.,INCLUDE,Molecular marker research
PMID:29750912,RAS signalling in energy metabolism and rare human diseases.,EXCLUDE,Signaling mechanism review
PMID:29762158,Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.,EXCLUDE,Diagnostic review
PMID:29765849,Magnetic Resonance of Myelin Water: AnÂ ,EXCLUDE,Incomplete title
PMID:29766474,Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton.,EXCLUDE,Review/descriptive article
PMID:29770198,Recent advances in managing/understanding meningioma.,EXCLUDE,Review article
PMID:29787563,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,INCLUDE,Computational network analysis tool
PMID:29796169,Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.,INCLUDE,Protein expression analysis
PMID:2983544,A discordant sibship analysis between beta-NGF and neurofibromatosis.,EXCLUDE,Genetic analysis without tool development
PMID:29847659,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,INCLUDE,Molecular mechanism study
PMID:29897904,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,INCLUDE,Drug discovery computational approach
PMID:29904909,Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.,EXCLUDE,Genetic mechanism description
PMID:29914349,Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.,INCLUDE,Clinical assessment tool
PMID:29925695,A porcine model of neurofibromatosis type 1 that mimics the human disease.,INCLUDE,Animal model development
PMID:29941005,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,INCLUDE,2D/3D cell culture model
PMID:29958847,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,INCLUDE,Radiomic biomarker analysis tool
PMID:29966337,In Vitro Transcriptome Response to a Mixture of ,EXCLUDE,Incomplete title
PMID:29982664,EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.,INCLUDE,Therapeutic target identification
PMID:29987129,Creating a comprehensive research strategy for cutaneous neurofibromas.,INCLUDE,Research strategy development
PMID:29987131,The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.,INCLUDE,Research priority setting tool
PMID:29987133,Clinical trial design for cutaneous neurofibromas.,INCLUDE,Clinical trial design methodology
PMID:30023349,Thyroid Gland ,EXCLUDE,Incomplete title
PMID:30055648,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,INCLUDE,Patient-derived xenograft model
PMID:30084351,[The impact of hormonal factors in meningioma development].,EXCLUDE,Hormonal factor review
PMID:30087692,Identification of Mutation Regions on ,EXCLUDE,Incomplete title
PMID:30104415,Germline and Somatic ,EXCLUDE,Incomplete title
PMID:30112810,Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.,INCLUDE,Drug targeting computational approach
PMID:30145722,Cerebrospinal Fluid Hyaluronan and Neurofibromatosis Type 2.,EXCLUDE,Biomarker description
PMID:30166301,Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.,INCLUDE,Clinical assessment protocol
PMID:30179114,Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.,INCLUDE,Neuroimaging analysis method
PMID:30181519,Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches.,INCLUDE,Computational protein interaction tool
PMID:3019128,"DNA ""fingerprints"" and segregation analysis of multiple markers in human pedigrees.",EXCLUDE,Genetic analysis method
PMID:30192842,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,INCLUDE,Machine learning predictive tool
PMID:30225235,A novel ,EXCLUDE,Incomplete title
PMID:30244634,MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting ,EXCLUDE,Incomplete title
PMID:30271432,Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study.,INCLUDE,Microscopy diagnostic tool
PMID:30274821,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,INCLUDE,Cell-based screening method
PMID:30274822,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,INCLUDE,Genetic variant prediction tool
PMID:30282421,"Simultaneous reconstruction of the forearm extensor compartment tendon, soft tissue, and skin.",EXCLUDE,Surgical technique
PMID:30284154,"Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.",INCLUDE,Clinical intervention trial
PMID:30290804,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,INCLUDE,Genetic diagnostic method
PMID:30302652,Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.,EXCLUDE,Network collaboration description
PMID:30335132,A proteasome-resistant fragment of NIK mediates oncogenic NF-ÎºB signaling in schwannomas.,INCLUDE,Molecular signaling mechanism
PMID:3037550,Molecular genetic approach to human meningioma: loss of genes on chromosome 22.,EXCLUDE,Genetic analysis description
PMID:30381327,Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).,INCLUDE,Proteomic interaction analysis tool
PMID:30470263,Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.,INCLUDE,Cellular mechanism study
PMID:30478082,Conditional Inactivation of ,EXCLUDE,Incomplete title
PMID:30478285,Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Molecular mechanism study
PMID:30479396,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,INCLUDE,Tumorigenesis mechanism
PMID:30542122,STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.,INCLUDE,Molecular targeting approach
PMID:30542514,Brief report on similar mutational changes in neurofibromatosis type 2 gene in minute pulmonary meningothelial-like nodule and meningioma of the central nervous system.,EXCLUDE,Brief case report
PMID:30571760,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,INCLUDE,Animal model development
PMID:30603728,Approach to wild-type gastrointestinal stromal tumors.,EXCLUDE,Clinical approach review
PMID:30615146,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,INCLUDE,Preclinical drug screening
PMID:30617350,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",INCLUDE,Animal disease model
PMID:30710873,Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.,INCLUDE,Neuroimaging analysis method
PMID:30713041,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,INCLUDE,Cell reprogramming method
PMID:30722027,"Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.",INCLUDE,Genetic mutation analysis
PMID:30728335,Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.,INCLUDE,Animal disease model
PMID:30737893,"Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.",INCLUDE,Clinical assessment tool
PMID:30744170,SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.,INCLUDE,Drug screening method
PMID:30796033,Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Drug resistance mechanism
PMID:30800298,A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.,INCLUDE,Qualitative research method
PMID:30816526,"MicroRNAâ92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.",EXCLUDE,Molecular mechanism description
PMID:3081724,Gene mapping and chromosome 19.,EXCLUDE,Genetic mapping description
PMID:3081725,Linkage analysis of peripheral neurofibromatosis (Von Recklinghausen disease) and chromosome 19 markers linked to myotonic dystrophy.,EXCLUDE,Genetic linkage analysis
PMID:30820037,Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.,INCLUDE,Epidemiological assessment tool
PMID:3082351,Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study.,EXCLUDE,Clinical outcome report
PMID:30850948,Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1.,INCLUDE,Molecular mechanism study
PMID:30859021,Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life.,INCLUDE,Clinical treatment assessment
PMID:30867289,EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.,INCLUDE,Molecular mechanism study
PMID:30886482,Asymptomatic Pinkish-Red Nodule over the Posterolateral Tongue.,EXCLUDE,Case report
PMID:30915713,Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions.,INCLUDE,Molecular mechanism study
PMID:3096370,Management of ipsilateral ptosis with hypotropia.,EXCLUDE,Clinical technique description
PMID:30971890,Schwann Cell Precursors; Multipotent Glial Cells in Embryonic Nerves.,INCLUDE,Cell biology mechanism
PMID:30984524,Next Generation Sequencing Identified a Novel Multi Exon Deletion of the ,INCLUDE,Genetic sequencing method
PMID:30996736,Congenital pseudarthrosis of the tibia: biological and biomechanical considerations to achieve union and prevent refracture.,EXCLUDE,Surgical technique description
PMID:3099820,Epidemiological investigations on neuroblastomas in Denmark 1943-1980.,EXCLUDE,Epidemiological report
PMID:31009417,Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.,INCLUDE,Pain mechanism research
PMID:31013682,The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis.,EXCLUDE,Molecular mechanism description
PMID:31015291,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,INCLUDE,Protein interaction mapping
PMID:31023785,Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.,INCLUDE,Epigenetic mechanism study
PMID:3102622,A computed image analyzing system for quantitation of melanocyte morphology in cafÃ©-au-lait macules of neurofibromatosis.,INCLUDE,Image analysis tool
PMID:31032403,RUNX represses ,EXCLUDE,Incomplete title
PMID:31033921,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,INCLUDE,Imaging diagnostic method
PMID:3103673,Ophthalmic manifestations of neurofibromatosis.,EXCLUDE,Clinical manifestation review
PMID:31043173,Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.,EXCLUDE,Diagnostic marker description
PMID:31044082,Discordant phenotype caused by ,EXCLUDE,Incomplete title
PMID:31053133,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,INCLUDE,Clinical assessment tool development
PMID:31053152,Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.,INCLUDE,Molecular mechanism study
PMID:31063758,YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.,INCLUDE,Molecular targeting approach
PMID:31081992,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.",INCLUDE,Clinical assessment tool
PMID:31091306,Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.,INCLUDE,Genetic mechanism study
PMID:31103079,Nerve Tumors of the Upper Extremity.,EXCLUDE,Clinical description
PMID:31111915,Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.,INCLUDE,Molecular mechanism study
PMID:31131338,Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits.,EXCLUDE,Surgical technique
PMID:31171721,Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival.,INCLUDE,Cellular metabolism mechanism
PMID:31178748,LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease.,EXCLUDE,Protein function review
PMID:3117984,SPECT imaging of para-axial neurofibromatosis with technetium-99m DTPA.,EXCLUDE,Imaging technique description
PMID:3118026,An exclusion map for Von Recklinghausen neurofibromatosis.,EXCLUDE,Genetic mapping description
PMID:3118028,Von Recklinghausen neurofibromatosis: a linkage study of candidate and random marker genes.,EXCLUDE,Genetic linkage analysis
PMID:3118030,Linkage analysis of neurofibromatosis.,EXCLUDE,Genetic linkage analysis
PMID:3118031,Genetic linkage studies with neurofibromatosis: the question of heterogeneity.,EXCLUDE,Genetic heterogeneity analysis
PMID:3118032,DNA linkage analysis in Von Recklinghausen neurofibromatosis.,EXCLUDE,Genetic linkage analysis
PMID:3118033,Linkage studies in peripheral neurofibromatosis.,INCLUDE,Genetic linkage study method
PMID:3118034,Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8.,INCLUDE,Genetic linkage analysis tool
PMID:3118035,Further exclusion data for the Von Recklinghausen neurofibromatosis gene: a genetic linkage study of 19 polymorphic markers.,INCLUDE,Genetic linkage exclusion method
PMID:31189476,Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.,INCLUDE,Quality of life assessment tool
PMID:31201114,Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis.,INCLUDE,Cellular communication mechanism
PMID:31201186,An auditory brainstem implant for treatment of unilateral tinnitus: protocol for an interventional pilot study.,INCLUDE,Clinical study protocol
PMID:31234911,Enriched expression of NF1 in inhibitory neurons in both mouse and human brain.,INCLUDE,Gene expression analysis
PMID:3124613,Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants.,EXCLUDE,Penetrance epidemiological study
PMID:31250618,Neurodevelopmental Aspects of RASopathies.,EXCLUDE,Review of neurodevelopmental aspects
PMID:31257748,Expression of ,EXCLUDE,Incomplete title
PMID:31291965,ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.,INCLUDE,Molecular mechanism study
PMID:31291992,COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake.,INCLUDE,Molecular expression analysis
PMID:31296571,Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.,INCLUDE,Protein phosphorylation mechanism
PMID:31312020,"The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.",INCLUDE,Protein interaction study
PMID:31386861,The Hippo Signaling Pathway in Development and Disease.,EXCLUDE,Signaling pathway review
PMID:31397088,Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST).,EXCLUDE,Clinical observation study
PMID:31427883,Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).,INCLUDE,Clinical trial protocol
PMID:31438995,Segmental schwannomatosis: characteristics in 12 patients.,EXCLUDE,Clinical case series
PMID:31443423,One ,EXCLUDE,Incomplete title
PMID:31468499,When Low Bone Mineral Density and Fractures Is Not Osteoporosis.,EXCLUDE,Clinical observation
PMID:31474359,Heterozygous Tumor Suppressor Microenvironment in Cancer Development.,EXCLUDE,Tumor microenvironment review
PMID:3149306,Neurofibromatosis in Nigerian children.,EXCLUDE,Epidemiological study
PMID:31511601,The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.,INCLUDE,Secretome analysis method
PMID:31545171,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis typeÂ 1.,INCLUDE,Animal model with optical monitoring
PMID:31558455,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,INCLUDE,Clinical study protocol
PMID:31558499,Carotid Artery Tortuosity Is Associated with Connective Tissue Diseases.,EXCLUDE,Clinical observation
PMID:31585900,NF2/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells.,INCLUDE,Molecular mechanism study
PMID:31594823,The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.,INCLUDE,Drug discovery research
PMID:31626572,"Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.",INCLUDE,Clinical trial protocol
PMID:31650029,STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation.,INCLUDE,Viral replication mechanism
PMID:31652930,The Role of Co-Deleted Genes in Neurofibromatosis Type 1 Microdeletions: An Evolutive Approach.,INCLUDE,Genetic deletion analysis
PMID:31652973,The Role of Merlin/NF2 Loss in Meningioma Biology.,INCLUDE,Molecular mechanism study
PMID:31673175,Short Term Results of a New Comprehensive Protocol for the Management of Congenital Pseudarthrosis of the Tibia.,EXCLUDE,Surgical procedure description
PMID:31730023,Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).,INCLUDE,Drug discovery research
PMID:31752929,The impact of RASopathy-associated mutations on CNS development in mice and humans.,INCLUDE,Comparative developmental study
PMID:31756343,Activation of PLCÎ³/AKT/IÎºBÎ±/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma.,INCLUDE,Molecular signaling mechanism
PMID:31763624,Sox2,EXCLUDE,Incomplete title
PMID:31793149,Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors.,INCLUDE,Collaborative research approach
PMID:31801570,"Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.",INCLUDE,Patient survey methodology
PMID:31836666,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,INCLUDE,Protein structural analysis
PMID:31836719,Engaging a community to enable disease-centric data sharing with the NF Data Portal.,INCLUDE,Data sharing platform development
PMID:31848332,A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,INCLUDE,Vaccine development research
PMID:31852972,AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma.,INCLUDE,Molecular interaction mechanism
PMID:31860870,Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice.,INCLUDE,Molecular mechanism study
PMID:31881853,A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.,INCLUDE,Clinical trial protocol
PMID:31888936,Perceived burden in dealing with different rare diseases: a qualitative focus group study.,EXCLUDE,Qualitative research study
PMID:31905340,The Sword of Damocles: Living with Neurofibromatosis Type 1.,EXCLUDE,Patient experience narrative
PMID:31913576,Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.,INCLUDE,Collaborative research approach
PMID:31915440,Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.,INCLUDE,Clinical assessment study
PMID:31917795,Soluble AXL as a marker of disease progression and survival in melanoma.,EXCLUDE,Biomarker observation
PMID:31927807,Rare Primary Retroperitoneal Neoplasms.,EXCLUDE,Case report
PMID:31936793,Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis.,INCLUDE,Molecular pathway analysis
PMID:31937162,Malignant peripheral nerve sheath tumor in the nasopharynx and oropharynx: a case report.,EXCLUDE,Case report
PMID:31940719,The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.,INCLUDE,Molecular mechanism study
PMID:31965112,Practical approach to diagnosis of bland-looking spindle cell lesions of the breast.,EXCLUDE,Diagnostic approach review
PMID:31979111,In-silico Analysis of ,EXCLUDE,Incomplete title
PMID:32014052,Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.,INCLUDE,Clinical guideline development
PMID:32075265,Bioactive Phenolic Compounds in the Modulation of Central and Peripheral Nervous System Cancers: Facts and Misdeeds.,EXCLUDE,Review of compounds
PMID:32089640,Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).,INCLUDE,Clinical trial protocol
PMID:32098059,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,INCLUDE,Integrative analysis method
PMID:32107864,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,INCLUDE,Genetic panel development
PMID:32108657,Diagnostic sequence for early diagnosis of neurofibromatosis type 1 using NIH criteria.,INCLUDE,Diagnostic criteria development
PMID:32144278,Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.,INCLUDE,Drug combination research
PMID:32147744,Legius Syndrome and its Relationship with Neurofibromatosis Type 1.,EXCLUDE,Syndrome relationship review
PMID:32152628,Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.,INCLUDE,Longitudinal tumor growth analysis
PMID:32176143,Contextualizing the Modern Epidemiology of Neurofibromatosis Type 2 in an Era of Heightened Detection of Sporadic Vestibular Schwannoma.,EXCLUDE,Epidemiological review
PMID:32181506,Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.,INCLUDE,Clinical assessment study
PMID:32182803,The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.,INCLUDE,Molecular mechanism study
PMID:32187457,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,INCLUDE,Clinical drug trial
PMID:32190165,Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.,INCLUDE,Clinical technology assessment
PMID:32193437,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,INCLUDE,Animal model development
PMID:32193699,Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.,INCLUDE,Biomarker identification
PMID:32194680,ADAM9: A novel player in vestibular schwannoma pathogenesis.,INCLUDE,Molecular mechanism study
PMID:32212796,The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.,INCLUDE,Immunohistochemistry method
PMID:32240795,Germline and sporadic cancers driven by the RAS pathway: parallelsÂ andÂ contrasts.,EXCLUDE,Review of cancer pathways
PMID:32245042,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,INCLUDE,Kinome profiling method
PMID:32252313,A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy.,INCLUDE,Novel treatment method
PMID:32252413,Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.,INCLUDE,Consortium research design
PMID:32272491,The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.,INCLUDE,Drug management study
PMID:32281771,Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.,INCLUDE,Genetic mutation analysis
PMID:32294191,Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.,INCLUDE,Clinical endocrine assessment
PMID:32299434,Merlin regulates signaling events at the nexus of development and cancer.,INCLUDE,Molecular signaling mechanism
PMID:32317644,Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,EXCLUDE,Author correction
PMID:32320652,Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.,INCLUDE,Drug design method
PMID:32352002,Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.,INCLUDE,3D cancer model development
PMID:32353955,New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Model system development
PMID:32354889,Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas ,INCLUDE,Drug mechanism study
PMID:32358581,Midkine activation of CD8,EXCLUDE,Incomplete title
PMID:32360730,Repeating or spacing learning sessions are strategies for memory improvement with shared molecular and neuronal components.,EXCLUDE,Learning and memory review
PMID:32383545,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,EXCLUDE,Incomplete title
PMID:32397722,NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA.,INCLUDE,Clinical diagnostic review
PMID:32406525,Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.,INCLUDE,Clinical assessment study
PMID:32408052,Mutation-Directed Therapeutics for Neurofibromatosis Type I.,INCLUDE,Therapeutic approach development
PMID:32419643,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,INCLUDE,Molecular mechanism study
PMID:32423401,Cardiac overload resolved by resection of a large plexiform neurofibroma on both the buttocks and upper posterior thighs in a patient with neurofibromatosis type I: a case report.,EXCLUDE,Case report
PMID:32438526,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,INCLUDE,Cell line characterization
PMID:32438819,Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.,INCLUDE,Drug design method
PMID:32443592,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,INCLUDE,Mechanism of pain study
PMID:32457840,"TGFÎ² Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",INCLUDE,Molecular signaling mechanism
PMID:32461556,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,INCLUDE,Organoid model development
PMID:32461616,"Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals.",EXCLUDE,Genetic variant analysis
PMID:32471868,Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.,INCLUDE,Animal model of NF1
PMID:32494228,Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.,EXCLUDE,Molecular targets review
PMID:32514759,"Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome.",EXCLUDE,Multidisciplinary center description
PMID:32560571,Telocytes in the Normal and Pathological Peripheral Nervous System.,EXCLUDE,Descriptive review
PMID:32571896,Haploinsufficiency of the ,EXCLUDE,Incomplete title
PMID:32599735,From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor.,EXCLUDE,Molecular landscape review
PMID:32601387,A molecular basis for neurofibroma-associated skeletal manifestations in NF1.,EXCLUDE,Molecular basis description
PMID:32608378,Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.,EXCLUDE,Pharmacological therapies review
PMID:32628746,NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.,EXCLUDE,Clinical risk factor analysis
PMID:32630080,Non-Autogenous Innovative Reconstruction Method Following Mandibulectomy.,EXCLUDE,Surgical reconstruction method
PMID:32638973,Reduced bone mineral content and density in neurofibromatosis type 1 and its association with nutrient intake.,EXCLUDE,Clinical observation
PMID:32642666,The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis.,EXCLUDE,Immune system review
PMID:32642668,Brain tumors in Neurofibromatosis type 1.,EXCLUDE,Brain tumor review
PMID:32642684,The inflammatory microenvironment in vestibular schwannoma.,EXCLUDE,Inflammatory microenvironment review
PMID:32642733,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,INCLUDE,Potential therapeutic targets
PMID:32642737,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,INCLUDE,Histological diagnostic tool
PMID:32642739,Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromes.,INCLUDE,Clinical trial design methodology
PMID:32642740,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,INCLUDE,Quality of life assessment tool
PMID:32642741,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,EXCLUDE,Neuroimaging observation
PMID:32655935,Inherited syndromes involving pancreatic neuroendocrine tumors.,EXCLUDE,Inherited syndrome review
PMID:32657748,The Neurofibromatoses.,EXCLUDE,Neurofibromatosis review
PMID:32694667,Functional and morphological cardiovascular alterations associated with neurofibromatosis 1.,EXCLUDE,Cardiovascular alterations description
PMID:32697994,Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.,EXCLUDE,Structural insights description
PMID:32699356,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,INCLUDE,Murine tumor model
PMID:32733046,Congenital abnormalities of the retinal vasculature in neurofibromatosis type I.,EXCLUDE,Clinical observation
PMID:32733557,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",INCLUDE,Bioinformatics analysis tool
PMID:32733558,Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.,EXCLUDE,Cancer prevention review
PMID:32781282,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,INCLUDE,Animal model characterization
PMID:32801276,"Social Independence of Patients with Neurofibromatosis Type 2 in Japan: Analysis of a National Registry of Patients Receiving Medical Expense Subsidies, 2004-2013.",EXCLUDE,Social independence analysis
PMID:3280697,"Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.",INCLUDE,Monoclonal antibody development
PMID:32814709,Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry.,EXCLUDE,Phenotype registry analysis
PMID:32839340,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,INCLUDE,Brain disruption animal model
PMID:32847614,Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.,EXCLUDE,Transcriptional network review
PMID:32858845,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,INCLUDE,Systems biology analysis tool
PMID:32869517,Genome-wide association study of cafÃ©-au-lait macule number in neurofibromatosis type 1.,INCLUDE,Genome-wide association study
PMID:32882803,"Special Issue: ""Genomics and Models of Nerve Sheath Tumors"".",EXCLUDE,Special issue description
PMID:32901776,Cutaneous manifestations in neurofibromatosis type 1.,EXCLUDE,Cutaneous manifestations review
PMID:32908010,Satisfaction from surgical treatment and its influence on the wellbeing of patients with Recklinghausen disease - preliminary report.,EXCLUDE,Surgical satisfaction survey
PMID:32948135,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,INCLUDE,In vitro cancer model
PMID:32960816,Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.,EXCLUDE,Schwannoma development mechanism
PMID:32977190,Motor cortical excitability and plasticity in patients with neurofibromatosis type 1.,EXCLUDE,Motor cortex excitability study
PMID:33023333,Serum-derived exosomes from neurofibromatosis type 1 congenital tibial pseudarthrosis impaired bone by promoting osteoclastogenesis and inhibiting osteogenesis.,EXCLUDE,Exosome characterization
PMID:33032988,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Cancer model and inhibition study
PMID:33061783,Subcutaneous neurofibroma as a cause of lameness in a warmblood horse: Neurofibroma in a horse.,EXCLUDE,Veterinary case report
PMID:33066259,Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design.,EXCLUDE,Biological activity review
PMID:33078583,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,INCLUDE,Cell autonomous requirement model
PMID:33080011,"Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.",INCLUDE,Genetic constraint analysis
PMID:33082502,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,INCLUDE,Image segmentation tool
PMID:33085177,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,INCLUDE,Patient-reported outcome measure development
PMID:33094349,Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.,EXCLUDE,Genetic mechanisms review
PMID:33117026,Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies.,EXCLUDE,Ocular anomalies description
PMID:33121128,"Neurofibromin Structure, Functions and Regulation.",EXCLUDE,Protein structure review
PMID:33160273,Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.,INCLUDE,Tumor cell reprogramming model
PMID:33197677,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,INCLUDE,Clinical intervention assessment tool
PMID:33209717,Germline predisposition to genitourinary rhabdomyosarcoma.,EXCLUDE,Cancer predisposition review
PMID:33233664,Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma.,EXCLUDE,Molecular mechanism review
PMID:33240020,Clinical picture and treatment of cutaneous lesions in patients with neurofibromatosis type 1.,EXCLUDE,Clinical lesion description
PMID:33273014,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,INCLUDE,Cellular model development
PMID:33279959,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",INCLUDE,Zebrafish tumor model
PMID:33356508,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,INCLUDE,Animal tumor model
PMID:33368180,A rare disease and education: Neurofibromatosis type 1 decreases educational attainment.,EXCLUDE,Educational attainment analysis
PMID:33375955,Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.,EXCLUDE,Radiosurgery technique review
PMID:33413690,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,INCLUDE,Single-cell RNA sequencing analysis
PMID:33414453,PLPP/CIN-mediated NF2-serine 10 dephosphorylation regulates F-actin stability and Mdm2 degradation in an activity-dependent manner.,EXCLUDE,Molecular mechanism description
PMID:33436083,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,INCLUDE,Epigenomic analysis
PMID:33442015,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,INCLUDE,Clinical trial of therapeutic intervention
PMID:33445724,Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.,EXCLUDE,Pathogenesis review
PMID:33447574,Pancreatic neuroendocrine tumours: spectrum of imaging findings.,EXCLUDE,Imaging findings review
PMID:33449435,The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases.,EXCLUDE,Pathway review
PMID:33470897,Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633ânm Red Light Illumination.,EXCLUDE,Therapeutic technique description
PMID:33484105,Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.,INCLUDE,Circulating DNA analysis
PMID:33486672,Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player.,EXCLUDE,Signaling pathway review
PMID:33507258,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,INCLUDE,Genomic database analysis tool
PMID:33507822,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,INCLUDE,Clinical trial methodology
PMID:33511762,Protein synthesis as a modifiable target for autism-related dendritic spine pathophysiologies.,EXCLUDE,Protein synthesis review
PMID:33519543,Autism Spectrum Disorder Symptom Profile Across the RASopathies.,EXCLUDE,Symptom profile description
PMID:33530415,Cutaneous Findings in Neurofibromatosis Type 1.,EXCLUDE,Cutaneous findings review
PMID:33541905,Longitudinal Assessment of Enhancing Foci of Abnormal Signal Intensity in Neurofibromatosis Type 1.,EXCLUDE,Longitudinal imaging study
PMID:33543019,Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.,EXCLUDE,Cancer marker description
PMID:33574490,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,INCLUDE,Antisense oligonucleotide development
PMID:33574795,Genetic and Epigenetic Causes of Pituitary Adenomas.,EXCLUDE,Genetic causes review
PMID:33588442,Diagnostic Pathology of Tumors of Peripheral Nerve.,EXCLUDE,Diagnostic pathology review
PMID:33591953,Chromosome 8 gain is associated with high-grade transformation in MPNST.,EXCLUDE,Chromosomal analysis
PMID:33604573,New developments in neurofibromatosis type 2 and vestibular schwannoma.,EXCLUDE,Disease development review
PMID:33622177,Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.,EXCLUDE,Molecular mechanism description
PMID:33625502,"Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.",INCLUDE,Clinical intervention assessment
PMID:33671872,Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1).,EXCLUDE,Risk factor analysis
PMID:33673681,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,INCLUDE,Splicing profile analysis tool
PMID:33721151,Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib.,EXCLUDE,Therapeutic development review
PMID:33730566,Distinct progenitor behavior underlying neocortical gliogenesis related to tumorigenesis.,EXCLUDE,Progenitor behavior description
PMID:33734413,Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.,EXCLUDE,Cancer prevalence comparison
PMID:33757576,Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.,EXCLUDE,Clinical observation
PMID:33767727,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,INCLUDE,Molecular diagnostic tool
PMID:33778620,Abdominal Vascular Complications in Neurofibromatosis Type 1.,EXCLUDE,Vascular complication description
PMID:33817379,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,INCLUDE,Clinical assessment tool
PMID:33818262,ABI-auditory brainstem implant.,EXCLUDE,Implant description
PMID:33850471,Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.,EXCLUDE,Molecular mechanism description
PMID:33863389,MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions.,EXCLUDE,Therapeutic review
PMID:33879870,Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma.,EXCLUDE,Genetic syndrome comparison
PMID:33903738,Identifying challenges in neurofibromatosis: a modified Delphi procedure.,EXCLUDE,Methodological review
PMID:33911094,"Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum.",EXCLUDE,Clinical association study
PMID:33946854,Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters.,EXCLUDE,Review of molecular mechanism
PMID:33948356,Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.,INCLUDE,Experimental drug mechanism
PMID:33954070,Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.,EXCLUDE,Clinical case report
PMID:33963463,The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.,EXCLUDE,Psychological impact study
PMID:33963966,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,INCLUDE,Cognitive assessment tool
PMID:33964370,Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.,EXCLUDE,Molecular mechanism review
PMID:33972401,Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies.,INCLUDE,Genetic model in Drosophila
PMID:34010628,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,INCLUDE,Stem cell research tool
PMID:34011935,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,INCLUDE,Potential therapeutic screening
PMID:34012067,Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.,EXCLUDE,Diagnostic criteria review
PMID:34020694,"The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.",EXCLUDE,Quality of life survey
PMID:34025587,Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.,EXCLUDE,Review of disease associations
PMID:34040258,NF1 mutation drives neuronalÂ activity-dependent initiation of optic glioma.,INCLUDE,Genetic mutation model
PMID:34040477,Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review.,EXCLUDE,Systematic literature review
PMID:34043012,RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.,INCLUDE,RNA sequencing analysis
PMID:34049498,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,INCLUDE,Auditory processing assessment
PMID:34053190,Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.,INCLUDE,Transcriptomic signature
PMID:34065204,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,INCLUDE,Cellular senescence model
PMID:34075397,PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).,INCLUDE,Genetic mouse model
PMID:34079083,WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.,INCLUDE,Tumor microenvironment model
PMID:34121041,"SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance.",EXCLUDE,Molecular signaling review
PMID:34123937,Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1.,EXCLUDE,Clinical case treatment
PMID:34131650,Irradiation of ,EXCLUDE,Incomplete title
PMID:34144233,RASopathies: The musculoskeletal consequences and their etiology and pathogenesis.,EXCLUDE,Review of musculoskeletal consequences
PMID:34155781,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,INCLUDE,Clinical trial assessment
PMID:34199217,Severe Phenotype in Patients with Large Deletions of ,EXCLUDE,Incomplete title
PMID:34215596,Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.,INCLUDE,Patient support intervention development
PMID:34229750,Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.,INCLUDE,Computational proteomics tool
PMID:34230196,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,INCLUDE,Clinical assessment tool
PMID:34230198,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,INCLUDE,Patient-reported outcome measure review
PMID:34230200,Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.,INCLUDE,Imaging evaluation tool
PMID:34230203,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,INCLUDE,Clinical trial recommendation tool
PMID:34230204,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,INCLUDE,Quality of life assessment tool
PMID:34230205,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,INCLUDE,Clinical trial endpoint recommendation
PMID:34230208,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,INCLUDE,Clinical trial methodology
PMID:34257279,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,INCLUDE,Genetic model in Drosophila
PMID:34257422,Increased risk for dementia in neurofibromatosis type 1.,EXCLUDE,Epidemiological study
PMID:34264955,Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.,INCLUDE,Drug screening method
PMID:34268254,Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders.,EXCLUDE,Review of telomerase dysfunction
PMID:34297428,RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.,INCLUDE,RNA sequencing analysis
PMID:34298962,Cd34+ Stromal Cells/Telocytes in Normal and Pathological Skin.,EXCLUDE,Cellular description
PMID:34337379,Conformational flexibility determines the Nf2/merlin tumor suppressor functions.,INCLUDE,Protein structure analysis
PMID:34345017,Tumorigenesis in neurofibromatosis type 1: role of the microenvironment.,EXCLUDE,Tumorigenesis review
PMID:34352618,Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation.,INCLUDE,Induced pluripotent stem cell line
PMID:34377779,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,INCLUDE,Neurocognitive assessment
PMID:34409538,Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.,EXCLUDE,Clinical association study
PMID:34416167,Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.,INCLUDE,Immunotherapy screening
PMID:34422615,The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.,EXCLUDE,Qualitative patient experience study
PMID:34428430,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,INCLUDE,Developmental window intervention model
PMID:34430126,Complications of Neurofibromatosis 1 (NF1) in an Adult With Multiple Comorbidities.,EXCLUDE,Clinical case report
PMID:34441036,Ultrasound-Guided Moving Shot Radiofrequency Ablation of Benign Soft Tissue Neoplasm.,EXCLUDE,Surgical technique
PMID:34445326,Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development.,EXCLUDE,Mechanism review
PMID:34464388,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,INCLUDE,Genomic sequencing method
PMID:34487172,Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.,INCLUDE,Machine learning diagnostic tool
PMID:34534577,Combined Cyclin-Dependent Kinase InhibitionÂ Overcomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I.,INCLUDE,Drug combination screening
PMID:34566848,Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.,EXCLUDE,Genetic mutation review
PMID:34570301,Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.,EXCLUDE,Psychological association study
PMID:34573290,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,INCLUDE,Genetic variant prediction tool
PMID:34576341,Blockade of Serotonin 5-HT,EXCLUDE,Incomplete title
PMID:34603530,Autophagy is involved in neurofibromatosis type I gene-modulated osteogenic differentiation in human bone mesenchymal stem cells.,INCLUDE,Cellular differentiation model
PMID:34604034,Neurofibromatosis: Molecular Pathogenesis and Natural Compounds as Potential Treatments.,EXCLUDE,Review of potential treatments
PMID:34604751,Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.,INCLUDE,Treatment feasibility study
PMID:34604833,Insights into the Pathogenesis of NF1-Associated Neoplasms.,EXCLUDE,Pathogenesis review
PMID:34626534,SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.,EXCLUDE,Genetic syndrome description
PMID:34627329,Executive functions and quality of life in children with neurofibromatosis type 1.,INCLUDE,Neuropsychological assessment
PMID:34630515,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,INCLUDE,CRISPR genetic engineering
PMID:34652463,Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis TypeÂ 2.,EXCLUDE,Long-term follow-up study
PMID:34664663,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,INCLUDE,Motor development assessment
PMID:34681018,Structural Protein Analysis of Driver Gene Mutations in Conjunctival Melanoma.,EXCLUDE,Protein mutation analysis
PMID:34692515,SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas.,INCLUDE,Molecular pathway model
PMID:34699786,Inhibition of ERK/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1.,INCLUDE,Therapeutic intervention model
PMID:34707296,The structure of neurofibromin isoform 2 reveals different functional states.,INCLUDE,Protein structure analysis
PMID:34728553,RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.,INCLUDE,Tumor differentiation model
PMID:34768015,Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience.,EXCLUDE,Treatment technique description
PMID:34779163,[Expert consensus on diagnosis and management of neurofibromatosis type 1 (2021 edition)].,EXCLUDE,Diagnostic consensus review
PMID:34782607,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,INCLUDE,RNA sequencing method
PMID:34793666,Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer.,EXCLUDE,Genetic testing study
PMID:34809690,Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.,EXCLUDE,Clinical association study
PMID:34870681,Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.,EXCLUDE,Clinical dysfunction description
PMID:34880260,Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.,INCLUDE,Cellular interaction model
PMID:34885143,Targeted Therapies for the Neurofibromatoses.,EXCLUDE,Review of targeted therapies
PMID:34897289,Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study.,EXCLUDE,Natural history study
PMID:34918118,Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.,INCLUDE,Genetic inactivation mechanism
PMID:34934133,MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy.,INCLUDE,Cellular pathway model
PMID:34935315,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,INCLUDE,Tissue imaging technique
PMID:34948100,Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.,INCLUDE,Molecular pathway model
PMID:34983638,Delineating the autistic phenotype in children with neurofibromatosis type 1.,INCLUDE,Autism phenotype assessment
PMID:34988263,"Magnetic resonance imaging of the brachial plexus. Part 1: Anatomical considerations, magnetic resonance techniques, and non-traumatic lesions.",EXCLUDE,Imaging technique review
PMID:34997843,Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?,EXCLUDE,Genetic variant study
PMID:35004058,Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1.,INCLUDE,Psychiatric comorbidity assessment
PMID:35008487,The Lipid Asset Is Unbalanced in Peripheral Nerve Sheath Tumors.,INCLUDE,Lipid analysis method
PMID:35037337,Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging.,INCLUDE,Imaging diagnostic method
PMID:35066574,Neurofibromin and suppression of tumorigenesis: beyond the GAP.,EXCLUDE,Molecular mechanism review
PMID:35101976,The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice.,EXCLUDE,Experimental injury model
PMID:35102991,Neurofibromatosis Type 1 Related Hydrocephalus.,EXCLUDE,Clinical condition description
PMID:35118300,Mediastinal tumors of peripheral nerve origin (so-called neurogenic tumors).,EXCLUDE,Tumor classification review
PMID:35118310,Sarcomas of the mediastinum with epithelioid morphology.,EXCLUDE,Tumor morphology description
PMID:35135568,A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1.,EXCLUDE,Quality of life survey
PMID:35140902,Mathematical Modeling and Nail Placement Accuracy Analysis of NF-1 Neurofibromatosis Scoliosis.,EXCLUDE,Surgical technique analysis
PMID:35156148,An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies.,EXCLUDE,Therapeutic landscape review
PMID:35160001,Morphological Relation of Peripheral Nerve Sheath Tumors and Nerve Fascicles: Prospective Study and Classification.,EXCLUDE,Morphological prospective study
PMID:35170228,Effect of food on capsule and granule formulations of selumetinib.,EXCLUDE,Pharmacokinetic study
PMID:35171800,[Neurodevelopmental disorders: from the laboratory to the classroom].,EXCLUDE,Neurodevelopmental review
PMID:35178568,The RASopathies: from pathogenetics to therapeutics.,EXCLUDE,Pathogenetics review
PMID:35187488,Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.,INCLUDE,Immune deconvolution computational tool
PMID:35188187,RAS and beyond: the many faces of the neurofibromatosis type 1 protein.,EXCLUDE,Protein mechanism review
PMID:35204451,Shear-Wave-Elastography in Neurofibromatosis Type I.,EXCLUDE,Imaging technique description
PMID:35212372,Characterizing mobile element insertions in 5675 genomes.,INCLUDE,Genomic mobile element characterization
PMID:35261809,A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway.,INCLUDE,Drug screening method
PMID:35266292,"The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.",EXCLUDE,Conference symposium summary
PMID:35325978,The Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Pathway in Osteoblasts.,EXCLUDE,Signaling pathway review
PMID:35328218,Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study.,EXCLUDE,Multicenter clinical study
PMID:35332608,Re-evaluation of missense variant classifications in NF2.,INCLUDE,Genetic variant reclassification
PMID:35334353,Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity.,EXCLUDE,Cognitive performance study
PMID:35337307,Could screw/hook insertion at the apical vertebrae with rib head dislocation effectively retract the corresponding rib head from spinal canal in dystrophic scoliosis secondary to type 1 neurofibromatosis?,EXCLUDE,Surgical technique description
PMID:35353986,Structural basis of activation of the tumor suppressor protein neurofibromin.,INCLUDE,Protein structural analysis
PMID:35371718,A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India.,EXCLUDE,Epidemiological cross-sectional study
PMID:35393544,"Malignant peripheral nerve sheath tumor: models, biology, and translation.",INCLUDE,Tumor model research
PMID:35394491,Function of the Retinal Pigment Epithelium in Patients With Neurofibromatosis Type 1.,EXCLUDE,Clinical patient assessment
PMID:35407641,"Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.",EXCLUDE,Clinical growth study
PMID:35419473,A therapeutic window for preventive therapy in NF1-associated optic pathway glioma.,EXCLUDE,Therapeutic window identification
PMID:35426432,Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.,INCLUDE,Radiomics analysis tool
PMID:35456477,Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism.,INCLUDE,Electrophysiological assessment method
PMID:35467749,Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.,EXCLUDE,Clinical drug trial
PMID:35478244,Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of Î²-catenin.,INCLUDE,Preclinical drug screening
PMID:35481324,Evaluating the Evidence: Scientometric Analysis of Highly Cited Neurofibromatosis 1 Publications.,INCLUDE,Scientometric analysis tool
PMID:35511749,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,High-throughput screening platform
PMID:35545829,Recent Update in Pharmacological Agents for Optic Pathway Glioma.,EXCLUDE,Pharmacological review
PMID:35546306,"A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.",EXCLUDE,Systematic review and meta-analysis
PMID:35579709,Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA.,EXCLUDE,Clinical burden assessment
PMID:35584348,Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.,INCLUDE,Tumor sequencing method
PMID:35589737,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,INCLUDE,Neuronal excitability model
PMID:35597953,Transition to adult care of young patients with neurofibromatosis type 1 and cognitive deficits: a single-centre study.,EXCLUDE,Clinical transition study
PMID:35599811,Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management.,EXCLUDE,Neurosurgical management review
PMID:35601964,Impact of neurofibromatosis type 1 in an adult community population.,EXCLUDE,Epidemiological population study
PMID:35625983,Mutation of ,EXCLUDE,Incomplete title
PMID:35628517,Molecular Dynamics Simulations Reveal Structural Interconnections within Sec14-PH Bipartite Domain from Human Neurofibromin.,INCLUDE,Molecular dynamics simulation
PMID:35657359,Management of neurofibromatosis type 1-associated plexiform neurofibromas.,EXCLUDE,Clinical management review
PMID:35673329,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,INCLUDE,Neuroanatomical correlation method
PMID:35677169,Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.,INCLUDE,Image-based tumor differentiation tool
PMID:35678462,"Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis.",EXCLUDE,Diagnostic delay study
PMID:35679001,Burden Among Caregivers of Pediatric Patients with Neurofibromatosis TypeÂ 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study.,EXCLUDE,Caregiver burden study
PMID:35687678,Gatekeeping role of ,EXCLUDE,Incomplete title
PMID:35708381,Thoracoscopic management of posterior mediastinal neurogenic tumours.,EXCLUDE,Surgical technique description
PMID:35723774,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,INCLUDE,Auditory device intervention
PMID:35729665,Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.,EXCLUDE,Dermatologic manifestation study
PMID:35735230,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,INCLUDE,Research tools database development
PMID:35740497,Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients.,EXCLUDE,Treatment review
PMID:35740680,Therapeutic Vulnerability to ATR Inhibition in Concurrent ,EXCLUDE,Incomplete title
PMID:35741605,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,INCLUDE,Drug mining computational tool
PMID:35756263,Sexual Self-Esteem and Psychological Burden of Adults With Neurofibromatosis Type 1.,EXCLUDE,Psychological impact study
PMID:35758466,NEUROFIBROMATOSIS TYPE I AND ITS DIAGNOSTIC CRITERIA: A CLINICAL OBSERVATION.,EXCLUDE,Clinical diagnostic criteria review
PMID:35759947,A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.,EXCLUDE,Clinical trials review
PMID:35784925,Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience.,EXCLUDE,Clinical management review
PMID:35815410,Schwann cell precursors represent a neural crest-like state with biased multipotency.,INCLUDE,Schwann cell precursor characterization
PMID:35838399,"Imprints of ""Scanxiety"".",EXCLUDE,Patient experience commentary
PMID:35854908,Surgical treatment of common peroneal neuropathy in schwannomatosis: illustrative cases.,EXCLUDE,Surgical case report
PMID:35855179,Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis.,INCLUDE,Bibliometric analysis tool
PMID:35855490,Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.,INCLUDE,Therapeutic target validation
PMID:35875109,Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.,INCLUDE,Preclinical drug screening
PMID:35875610,"CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.",INCLUDE,Drug efficacy screening
PMID:35879407,Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.,INCLUDE,Genetic mechanism investigation
PMID:35887576,Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.,INCLUDE,Nanoparticle treatment screening
PMID:35936291,Early Developmental Trajectories in Infants With Neurofibromatosis 1.,EXCLUDE,Developmental trajectory study
PMID:35955749,CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.,EXCLUDE,Drug resistance mechanism study
PMID:35965583,Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors.,INCLUDE,Drug combination screening
PMID:35968018,Loss of H3K27me3 expression in canine nerve sheath tumors.,INCLUDE,Molecular expression analysis
PMID:35970940,"Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.",INCLUDE,Clinical intervention trial
PMID:36001333,Neurofibromatosis Type 1 and Risk of Skin Cancer.,EXCLUDE,Epidemiological risk study
PMID:36009591,Identification of Germinal Neurofibromin Hotspots.,INCLUDE,Genetic hotspot identification
PMID:36037004,Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.,INCLUDE,Animal model research
PMID:36056180,Nervous system (NS) Tumors in Cancer Predisposition Syndromes.,EXCLUDE,Tumor syndrome review
PMID:36059985,Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma.,INCLUDE,Preclinical drug screening
PMID:36071954,Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration.,INCLUDE,Cell culture method
PMID:36081238,Plasticity of visual evoked potentials in patients with neurofibromatosis type 1.,INCLUDE,Electrophysiological assessment
PMID:36092522,Gingival and alveolar ridge overgrowths: A histopathological evaluation from Saudi Arabia.,EXCLUDE,Histopathological evaluation
PMID:36109609,Deciphering the therapeutical potentials of rosmarinic acid.,EXCLUDE,Therapeutic potential review
PMID:36111466,[Treatment and progress of cutaneous neurofibroma].,EXCLUDE,Treatment review
PMID:36127120,Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.,INCLUDE,Cohort profile development
PMID:36127977,Vertebral Artery Stenosis: A Narrative Review.,EXCLUDE,Narrative review
PMID:36130486,Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.,INCLUDE,Single-cell sequencing method
PMID:36134175,The Application of Contrast-Enhanced 3D-STIR-VISTA MR Imaging of the Brachial Plexus.,EXCLUDE,Imaging technique description
PMID:36134665,Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.,INCLUDE,Tumor microenvironment characterization
PMID:36139671,Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.,INCLUDE,Cellular origin investigation
PMID:36188467,Ras GTPase-activating proteins control neuronal circuit development in barrel cortex layer 4.,EXCLUDE,Neuronal circuit development study
PMID:36215287,Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?,EXCLUDE,Cognitive comparison study
PMID:36230612,"Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3.",EXCLUDE,Diagnostic strategy review
PMID:36241865,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,INCLUDE,Stem cell transplantation method
PMID:36300003,A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.,INCLUDE,Genetic splicing mechanism study
PMID:36302602,Malignant Melanotic Nerve Sheath Tumor.,EXCLUDE,Case report
PMID:36316421,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,INCLUDE,Brain stimulation intervention
PMID:36325164,Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin.,EXCLUDE,Genetic contribution study
PMID:36332985,Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.,EXCLUDE,Longitudinal imaging study
PMID:36335228,Abnormal peripheral blood cell counts in neurofibromatosis type 1.,EXCLUDE,Blood cell count analysis
PMID:36335782,Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.,EXCLUDE,Regulatory strategy meeting
PMID:36405824,Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.,EXCLUDE,Retrospective multicenter study
PMID:36416236,LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.,INCLUDE,Molecular migration analysis
PMID:36420221,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,INCLUDE,Genetic rescue method
PMID:36444392,Characterization of health concerns in people with neurofibromatosis type 1.,EXCLUDE,Clinical health concerns review
PMID:36459048,Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.,INCLUDE,Molecular disease characterization
PMID:36468211,"Hereditary breast cancer: syndromes, tumour pathology and molecular testing.",EXCLUDE,Hereditary cancer review
PMID:36471422,Anti-stress effects of Fameyes in in vitro and in vivo models of stresses.,EXCLUDE,Anti-stress effects study
PMID:36497280,Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs.,INCLUDE,Cell proliferation knockdown experiment
PMID:36598023,Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study.,EXCLUDE,Clinical treatment retrospective study
PMID:36604703,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,INCLUDE,Quality of life questionnaire validation
PMID:36619222,Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma.,INCLUDE,Drug sensitivity experimental study
PMID:36684394,ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.,EXCLUDE,Clinical surveillance guidelines
PMID:36689660,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,INCLUDE,Genetic variant mechanism study
PMID:36730269,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,INCLUDE,Spheroid drug screening method
PMID:36742908,"Ptosis, Visual Blurring, and Multiple Cranial Nerve Tumors: Do We Know the Culprit.",EXCLUDE,Clinical case description
PMID:36759572,Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis.,INCLUDE,Molecular pathogenesis mechanism
PMID:36806881,Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.,INCLUDE,Potential therapeutic pathway study
PMID:36809290,Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.,INCLUDE,Molecular protein interaction study
PMID:36823650,"Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: a systematic review.",EXCLUDE,Systematic review of psychosocial impacts
PMID:36825950,How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma.,EXCLUDE,Clinical rehabilitation strategy
PMID:36832459,"Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.",EXCLUDE,Psychological impact assessment
PMID:36844630,Genetic variants of cancerâassociated genes analyzed using nextâgeneration sequencing in small sporadic vestibular schwannomas.,INCLUDE,Genetic sequencing analysis
PMID:36849412,Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.,INCLUDE,Animal model drug combination study
PMID:36854987,Modeling nervous system tumors with human stem cells and organoids.,INCLUDE,Stem cell and organoid modeling
PMID:36857802,Rare malignant peripheral nerve sheath tumor of vagus nerve: A case report.,EXCLUDE,Clinical case report
PMID:36866403,Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.,INCLUDE,Epigenetic characterization method
PMID:36868466,A Two-Stage End-to-End Deep Learning Framework for Pathologic Examination in Skin Tumor Diagnosis.,INCLUDE,Deep learning diagnostic tool
PMID:36890585,NeurofibromatosisÂ type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,INCLUDE,Mouse microglia functional study
PMID:36895472,MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.,INCLUDE,Molecular inhibition mechanism
PMID:36944680,Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.,INCLUDE,Cellular mechanism investigation
PMID:36959711,Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.,INCLUDE,CRISPR genetic modeling
PMID:36976677,Generation of human iPSC-derived neurofibromaspheres for inÂ vitro and inÂ vivo uses.,INCLUDE,iPSC-derived model generation
PMID:36996759,Motor Function and Physiology in Youth With Neurofibromatosis Type 1.,EXCLUDE,Motor function clinical assessment
PMID:37010875,"Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.",EXCLUDE,Clinical treatment study
PMID:37025569,Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis.,EXCLUDE,Clinical dysfunction assessment
PMID:37115514,Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.,EXCLUDE,Clinical drug safety study
PMID:37140985,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,INCLUDE,Extracellular matrix characterization
PMID:37147639,The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1.,INCLUDE,Molecular interaction mechanism
PMID:37164978,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,INCLUDE,Multiplatform molecular profiling
PMID:37173460,Neurofibromatosis type 1-associated plexiform neurofibromas of the neck: topography of lesions and surgical treatment data of 69 patients.,EXCLUDE,Clinical surgical description
PMID:37174657,Deletion of ,EXCLUDE,Incomplete title
PMID:37174998,Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?,EXCLUDE,Pulmonary disease review
PMID:37185294,"A Targeted, Low-Throughput Compound Screen in a ",EXCLUDE,Incomplete title
PMID:37186028,Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II.,INCLUDE,Genetic variant analysis
PMID:37189588,Neurofibromatosis Symptom-Lacking B-Cell Lineage Acute Lymphoblastic Leukemia with Only an ,EXCLUDE,Clinical case report
PMID:37217626,New insights into the molecular basis of spinal neurofibromatosis type 1.,INCLUDE,Molecular basis investigation
PMID:37217995,The genetic landscape and possible therapeutics of neurofibromatosis type 2.,INCLUDE,Genetic landscape study
PMID:37218842,Hearing Rehabilitation in Vestibular Schwannoma.,EXCLUDE,Clinical rehabilitation description
PMID:37245145,"RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.",INCLUDE,Molecular signaling mechanism
PMID:37246765,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,INCLUDE,Ex vivo/in vivo tumor modeling
PMID:37275115,Managing Multiple Schwannomatosis of Vagus and Hypoglossal Nerves: The Unanticipated Complications.,EXCLUDE,Clinical case management
PMID:37276689,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,INCLUDE,Quality of life questionnaire study
PMID:37287695,"Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study.",EXCLUDE,Clinical drug trial
PMID:37294265,Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal.,EXCLUDE,Clinical multidisciplinary review
PMID:37301319,Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.,INCLUDE,Transcriptional profile analysis
PMID:37318402,Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.,EXCLUDE,Clinical tumor burden assessment
PMID:37328781,Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.,EXCLUDE,Clinical treatment decision study
PMID:37330719,Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.,INCLUDE,Preclinical model development
PMID:37345107,Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments.,EXCLUDE,Clinical treatment review
PMID:37353803,Blunted circadian variation of blood pressure in individuals with neurofibromatosis type 1.,EXCLUDE,Clinical blood pressure study
PMID:37353850,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,INCLUDE,Questionnaire translation/validation
PMID:37370749,Integrated Neurosurgical Management of Retroperitoneal Benign Nerve Sheath Tumors.,EXCLUDE,Clinical surgical management
PMID:37378983,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,INCLUDE,Quality of life intervention study
PMID:37382486,A new era for myelin research in Neurofibromatosis type 1.,INCLUDE,Myelin research investigation
PMID:37401302,Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.,EXCLUDE,Clinical treatment review
PMID:37406085,Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.,INCLUDE,Molecular drug combination study
PMID:37417633,Renal artery aneurysm induced by neurofibromatosis type 1: A case report and review of the endovascular interventions for this rare vasculopathy.,EXCLUDE,Clinical case report
PMID:37435433,Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers.,INCLUDE,Genetic mutation profiling
PMID:37440099,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,INCLUDE,Virtual intervention study
PMID:37443782,Toward an Early Diagnosis for Alzheimer's Disease Based on the Perinuclear Localization of the ATM Protein.,EXCLUDE,Alzheimer's diagnostic review
PMID:37446790,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,INCLUDE,Cell model genetic knockout
PMID:37460655,The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland.,EXCLUDE,Epidemiological labor market study
PMID:37509275,Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1.,EXCLUDE,Clinical sensory processing assessment
PMID:37520682,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,INCLUDE,Genetic therapy approach
PMID:37527526,Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.,INCLUDE,Molecular pathway inhibition study
PMID:37608248,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,INCLUDE,EEG resting state analysis
PMID:37616542,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",INCLUDE,Drug combination screening
PMID:37627552,The Contribution of Oxidative Stress to ,EXCLUDE,Incomplete title
PMID:37629179,Drug Repositioning for Refractory Benign Tumors of the Central Nervous System.,INCLUDE,Drug repositioning approach
PMID:37635082,Neurofibromatosis 1 (von Recklinghausen Disease).,EXCLUDE,Clinical disease overview
PMID:37659342,Electrically evoked auditory responses: A classification for brainstem implant placement in Neurofibromatosis Type 2.,INCLUDE,Auditory response classification
PMID:37680255,The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?,EXCLUDE,Immunotherapy review
PMID:37686402,"FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.",INCLUDE,Molecular therapeutic targeting
PMID:37712888,A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells.,INCLUDE,Genetic variant mechanism study
PMID:37728798,[Cosmetic and functional results after resection of cutaneous neurofibroma in neurofibromatosisÂ typeÂ 1 : Operation of neurofibroma improves quality of life while having moderate complications].,EXCLUDE,Clinical surgical outcomes
PMID:37732340,"Coexistence of a small bowel gastrointestinal stromal tumor, small bowel adenocarcinoma and ganglioneuroma in a patient with neurofibromatosis type I caused intussusception.",EXCLUDE,Clinical case report
PMID:37753674,Diagnostic value of high-frequency ultrasound (HFUS) in evaluation of subcutaneous lesions.,EXCLUDE,Clinical diagnostic technique
PMID:37760547,Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1).,INCLUDE,Molecular therapeutic targeting
PMID:37770931,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",INCLUDE,Single-nuclei RNA sequencing
PMID:37772407,Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.,INCLUDE,Clinical assessment endpoint development
PMID:37786375,Culture of attenuated ,EXCLUDE,Incomplete title
PMID:37791039,Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of ,EXCLUDE,Clinical case report
PMID:37817770,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,INCLUDE,Single-cell RNA sequencing
PMID:37848948,Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas.,EXCLUDE,Animal model nutritional study
PMID:37891793,The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma.,EXCLUDE,Immunological review
PMID:37892022,Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence.,EXCLUDE,Clinical mutation study
PMID:37893091,Dermoscopic Patterns of Genodermatoses: A Comprehensive Analysis.,EXCLUDE,Clinical diagnostic review
PMID:37908901,"A Lesion on the ""King of Kings"": Neurofibromas in the Parthian Empire's Arsacid Dynasty.",EXCLUDE,Historical case description
PMID:37929436,"Preoperative Wire Localization: A Simple Guidance Technique for Excision of Deep, Painful, Small, Soft Tissue Neurofibromas.",EXCLUDE,Clinical surgical technique
PMID:37949359,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.,INCLUDE,Immune cell characterization
PMID:37958460,"Oncological Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health after Pencil-Beam Scanning Proton Therapy in Patients with Low-Grade Glioma.",EXCLUDE,Clinical treatment outcomes
PMID:37962219,Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.,EXCLUDE,Clinical survey methodology
PMID:37990867,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,INCLUDE,Induced pluripotent stem cell modeling
PMID:37996843,Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey.,EXCLUDE,Quality of life survey
PMID:38000811,Epithelioid malignant peripheral nerve sheath tumour of the ulnar nerve around the elbow: a diagnostic and therapeutic challenge.,EXCLUDE,Clinical case report
PMID:38001599,"Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis.",EXCLUDE,Biomarker review
PMID:38008284,Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.,INCLUDE,Genetic characterization tool (droplet digital PCR)
PMID:38009710,"Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.",EXCLUDE,Intervention study without specific tool
PMID:38057084,Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.,EXCLUDE,Quality of life survey
PMID:38086379,Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.,INCLUDE,Drug screening in cell lines
PMID:38107530,Introducing Albumin and Interleukin 6 as Common Critical Dysregulated Proteins Between Migraine and Gliosarcoma.,EXCLUDE,Protein analysis review
PMID:38114312,[Application of peroral endoscopic-assisted laryngeal microsurgery in children with laryngeal neurofibromas].,EXCLUDE,Surgical procedure description
PMID:38115252,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,INCLUDE,Bioinformatics gene identification tool
PMID:38127282,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,INCLUDE,Spatial gene expression profiling
PMID:38131619,Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.,EXCLUDE,Clinical observation
PMID:38136356,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,INCLUDE,Drug response in cell lines
PMID:38140900,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,INCLUDE,Clinical assessment tool development
PMID:38170419,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,INCLUDE,Patient-reported outcome measure development
PMID:38173515,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,INCLUDE,MRI segmentation technique
PMID:38175707,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,INCLUDE,Molecular pathway investigation
PMID:38179770,Cancer Stem Cell Biomarkers in the Nervous System.,EXCLUDE,Biomarker review
PMID:38187038,Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.,INCLUDE,Drug combination screening
PMID:38201517,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,INCLUDE,Xenograft model development
PMID:38203448,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,INCLUDE,Cellular mechanism investigation
PMID:38216123,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,INCLUDE,Metabolic pathway analysis
PMID:38225833,[Gene therapy strategies and prospects for neurofibromatosis type 1].,EXCLUDE,Gene therapy review
PMID:38229454,Estrogen-induced glial IL-1Î² mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma.,INCLUDE,Animal model investigation
PMID:38258905,Schwann cells modulate nociception in neurofibromatosis 1.,INCLUDE,Cellular mechanism study
PMID:38260834,Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.,EXCLUDE,Clinical case series
PMID:38279591,Global research trends in cutaneous neurofibromas: A bibliometric analysis from 2003 to 2022.,EXCLUDE,Bibliometric analysis
PMID:38308315,Brain injury drives optic glioma formation through neuron-glia signaling.,INCLUDE,Animal model investigation
PMID:38318960,The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.,EXCLUDE,Virtual intervention study
PMID:38321701,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,INCLUDE,Patient-reported outcome measure development
PMID:38336988,Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.,INCLUDE,Preclinical drug screening
PMID:38339230,Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.,INCLUDE,Animal model investigation
PMID:38360927,Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors.,INCLUDE,Cellular mechanism study
PMID:38366576,Perceived transition readiness among adolescents and young adults with neurofibromatosis type 1 and plexiform neurofibromas: a cross-sectional descriptive study.,EXCLUDE,Cross-sectional survey
PMID:38372904,Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.,INCLUDE,Imaging biomarker development
PMID:38387803,Development of a vestibular schwannoma tumor slice model for pharmacological testing.,INCLUDE,Tumor slice model development
PMID:38402381,Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.,EXCLUDE,Quality of life survey
PMID:38409461,Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.,EXCLUDE,Intervention study
PMID:38413225,Multimodal Imaging of Choroidal Nodules in Neurofibromatosis Type I.,EXCLUDE,Imaging description
PMID:38458648,C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.,INCLUDE,Molecular mechanism investigation
PMID:38463630,Interactions between Ras and Rap signaling pathways during neurodevelopment in health and disease.,INCLUDE,Signaling pathway analysis
PMID:38465768,Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.,EXCLUDE,Long-term clinical outcomes
PMID:38473354,The ,EXCLUDE,Incomplete title
PMID:38475852,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,EXCLUDE,Telehealth intervention study
PMID:38480916,p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.,INCLUDE,Molecular mechanism investigation
PMID:38481529,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,INCLUDE,Genetic reagent development (CRISPR cell lines)
PMID:38493052,Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.,EXCLUDE,Quality of life survey
PMID:38499890,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",INCLUDE,Patient-reported outcome measure validation
PMID:38502231,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,INCLUDE,Immunotherapy mechanism study
PMID:38520250,Risk factors for glioblastoma are shared by other brain tumor types.,EXCLUDE,Risk factor review
PMID:38521834,The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.,EXCLUDE,Quality of life survey
PMID:38542016,Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management.,EXCLUDE,Clinical treatment description
PMID:38560379,Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.,EXCLUDE,Clinical observation
PMID:38565263,A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion.,EXCLUDE,Histological characterization
PMID:38591341,Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome.,EXCLUDE,Genetic testing description
PMID:38592693,The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review.,EXCLUDE,Systematic review
PMID:38595983,Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.,INCLUDE,Viral therapy development
PMID:38603731,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,INCLUDE,Computational analysis tool (U-Net)
PMID:38607967,NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.,INCLUDE,Animal model investigation
PMID:38623309,Supplementation of Heat-Treated ,EXCLUDE,Incomplete title
PMID:38630491,Examining Sex Differences in Autism Heritability.,EXCLUDE,Heritability study
PMID:38641672,The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling.,EXCLUDE,Molecular mechanism review
PMID:38646284,Peripheral Nerve Sheath Tumor: A Diagnostic and Therapeutic Challenge.,EXCLUDE,Clinical review
PMID:38654147,Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.,EXCLUDE,Genetic case report
PMID:38680880,Neurofibromatosis Type 1: Optimizing Management with a Multidisciplinary Approach.,EXCLUDE,Clinical management review
PMID:38691597,Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.,INCLUDE,Drug efficacy study
PMID:38703433,Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.,EXCLUDE,Clinical review
PMID:38709422,"Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors.",EXCLUDE,Therapeutic review
PMID:38710002,Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Clinical review
PMID:38714355,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,INCLUDE,Preclinical drug mechanism
PMID:38721358,Effect of food on selumetinib pharmacokinetics and gastrointestinal tolerability in adolescents with neurofibromatosis type 1-related plexiform neurofibromas.,EXCLUDE,Pharmacokinetic study
PMID:38722890,NF-ÎºB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.,INCLUDE,Animal model investigation
PMID:38744742,Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder.,EXCLUDE,Treatment technique description
PMID:38760612,"Gene Therapy for Neurofibromatosis TypeÂ 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.",EXCLUDE,Gene therapy review
PMID:38769783,Surgical Treatment Outcomes of Anterior-Only Correction and Reconstruction for Severe Cervical Kyphotic Deformity with Neurofibromatosis-1: A Retrospective Study with a 5-Year Follow-Up.,EXCLUDE,Surgical outcomes
PMID:38783059,Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology.,INCLUDE,Deep learning computational tool
PMID:38805733,Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-blinded Placebo-controlled Study.,EXCLUDE,Secondary analysis of intervention
PMID:38811427,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,INCLUDE,Quality of life tool validation
PMID:38816530,Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.,INCLUDE,Animal model investigation
PMID:38828669,PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas.,INCLUDE,Molecular mechanism investigation
PMID:38847227,RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.,EXCLUDE,Signaling pathway review
PMID:38869947,Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT.,EXCLUDE,Clinical trial summary
PMID:38874808,"Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes.",INCLUDE,Genetic mechanism investigation
PMID:38879607,G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells.,INCLUDE,Molecular mechanism investigation
PMID:38879686,NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.,EXCLUDE,Molecular mechanism review
PMID:38893191,Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors.,EXCLUDE,Syndrome review
PMID:38895115,Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.,INCLUDE,Viral therapy development
PMID:38897938,Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis.,EXCLUDE,Diagnostic criteria review
PMID:38900740,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,INCLUDE,Animal model development
PMID:38913608,Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).,INCLUDE,Animal model investigation
PMID:38918262,Surgical options of chiasmatic hypothalamic glioma-a relevant part of therapy in an interdisciplinary approach for tumor control.,EXCLUDE,Surgical technique description
PMID:38923198,Adaption of neurosurgical resection patterns for pediatric low-grade glioma spanning two decades-Report from the German LGG-studies 1996-2018.,EXCLUDE,Surgical pattern review
PMID:38923593,The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.,EXCLUDE,Quality of life survey
PMID:38924432,MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by ,INCLUDE,Molecular mechanism investigation
PMID:38927491,Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.,EXCLUDE,Therapeutic approach review
PMID:38928264,NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues.,EXCLUDE,Molecular mechanism review
PMID:38931352,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,INCLUDE,Imaging tracer development
PMID:38932491,NF1,EXCLUDE,Incomplete title
PMID:38945076,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,INCLUDE,Molecular mechanism investigation
PMID:38975694,Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.,EXCLUDE,Clinical trial summary
PMID:38990917,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,INCLUDE,Clinical assessment tool for optic pathway gliomas
PMID:38994676,Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments.,EXCLUDE,Spatial landscape review
PMID:38995012,The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Peptide-based anti-neoplastic approach
PMID:39001468,Genotype-Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of ,INCLUDE,Genetic variant analysis method
PMID:39002525,Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.,EXCLUDE,Symptom comparison review
PMID:39005234,TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma.,EXCLUDE,Signaling pathway review
PMID:39015391,"Measures of youth e-cigarette use: strengths, weaknesses and recommendations.",EXCLUDE,Measurement methodology review
PMID:39016685,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,INCLUDE,Chemical genetic screening method
PMID:39022466,"Investigating the Prevalence, Gender Predilection, and Inheritance Patterns of Genodermatoses: A Tertiary Hospital Study.",EXCLUDE,Prevalence study
PMID:39022906,Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome.,INCLUDE,Phenotype expansion methodology
PMID:39023130,Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of neurofibromatosis type 1 optic pathway glioma.,INCLUDE,Animal model research
PMID:39054162,Do metabolic deficits contribute to sleep disruption in monogenic intellectual disability syndromes?,EXCLUDE,Metabolic deficit review
PMID:39059735,Longitudinal changes in retinal ganglion cell function in optic pathway glioma evaluated by photopic negative response.,INCLUDE,Longitudinal functional assessment tool
PMID:39061138,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,INCLUDE,3D cell culture model
PMID:39083549,Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.,INCLUDE,Pathway inhibitor screening
PMID:39094827,Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas.,INCLUDE,Molecular mechanism investigation
PMID:39100928,NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14.,INCLUDE,Molecular pathway blockade method
PMID:39106942,Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model.,INCLUDE,Therapeutic nonsense suppression mouse model
PMID:39110684,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,INCLUDE,Electrospun cell culture platform
PMID:39129390,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,INCLUDE,Autophagy inhibition therapeutic approach
PMID:39140257,Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple cafÃ©-au-lait macules.,INCLUDE,Genetic variant analysis method
PMID:39165673,INTRATHECAL BACLOFEN FOR NEUROFIBROMATOSIS RELATED SPINAL CORD INJURY WITH SPASTICITY - A CASE REPORT.,EXCLUDE,Clinical case report
PMID:39176108,Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research.,EXCLUDE,Gene mutation review
PMID:39179860,Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.,INCLUDE,Potential therapeutic targeting approach
PMID:39185400,Total Knee Arthroplasty in a Patient With Neurofibromatosis 1.,EXCLUDE,Surgical case report
PMID:39193326,Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example.,INCLUDE,Pharmacological analysis method
PMID:39196570,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.,INCLUDE,Quality of life assessment tool
PMID:39198186,Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan.,INCLUDE,Quality of life assessment tool
PMID:39201967,"Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.",INCLUDE,Quality of life assessment tool
PMID:39210910,Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain.,INCLUDE,Genetic pathway impact analysis
PMID:39211690,Plexiform Neurofibroma: A Case Report.,EXCLUDE,Clinical case report
PMID:39216515,An Atypical Mechanism of SUMOylation of Neurofibromin SecPH Domain Provides New Insights into SUMOylation Site Selection.,INCLUDE,Molecular mechanism investigation
PMID:39217323,Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.,INCLUDE,Neuronal and metabolic alteration analysis
PMID:39225289,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,INCLUDE,3D imaging measurement tool
PMID:39234078,"Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.",INCLUDE,Quality of life assessment tool
PMID:3925026,"Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma.",EXCLUDE,Protein composition study
PMID:39254838,Genetic basis and imaging findings of neurofibromatosis 1 and other somatic overgrowth disorders.,EXCLUDE,Genetic and imaging review
PMID:39257551,Diagnosis and management of neurofibromatosis type 1 in Arabian Gulf Cooperation Council Region: challenges and recommendations.,EXCLUDE,Clinical management review
PMID:39258154,LZTR1 loss-of-function variants associated with cafÃ© au lait macules with or without freckling.,INCLUDE,Genetic variant analysis method
PMID:39273214,Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,INCLUDE,Molecular expression analysis
PMID:3930616,Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study.,EXCLUDE,Cellular marker study
PMID:39321200,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,INCLUDE,Immunotyping methodology
PMID:39335500,Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells.,INCLUDE,Cellular response to plasma treatment
PMID:39336731,The Prevalence of Cancer Predisposition Syndromes (CPSs) in Children with a Neoplasm: A Cohort Study in a Central and Eastern European Population.,EXCLUDE,Prevalence study
PMID:39355740,Pigment epithelium derived factor drives melanocyte proliferation and migration in neurofibromatosis cafÃ© au lait macules.,INCLUDE,Molecular mechanism investigation
PMID:39359760,Managing neurofibromatosis type I and vision impairment in a resource-limited setting: a case study and multidisciplinary approach.,EXCLUDE,Clinical case management
PMID:39373898,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,INCLUDE,Computational mutation analysis tool
PMID:39395123,"Autism Spectrum Disorder Symptom Profiles in Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis Complex and Neurofibromatosis Type 1.",EXCLUDE,Symptom profile comparison
PMID:39403336,Duodenal ampulla neuroendocrine tumor and gastrointestinal stromal tumors in a case of neurofibromatosis type 1: a case report.,EXCLUDE,Clinical case report
PMID:39409151,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,INCLUDE,Genome profiling method
PMID:39413183,Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance.,INCLUDE,Immunological mechanism investigation
PMID:39415595,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,INCLUDE,Animal model development
PMID:39433486,[Several suggestions for improving diagnosis and management of patients with neurofibromatosis type 1].,EXCLUDE,Diagnostic recommendation review
PMID:39433487,[Clarification the terms and definitions related to neurofibromatosis type 1].,EXCLUDE,Terminology clarification
PMID:39433488,[Progress and prospects in diagnosis and treatment of neurofibromatosis type 1].,EXCLUDE,Diagnostic review
PMID:39433489,[Progress in neurosurgical treatment of neurofibromatosis type 1].,EXCLUDE,Surgical treatment review
PMID:39433490,[Emergency management and perioperative strategies for intra-tumoral hemorrhage in neurofibromatosis type 1-related giant plexiform neurofibroma].,EXCLUDE,Surgical management review
PMID:39454246,Effectiveness of CI as an alternative to ABI for hearing loss in patients with vestibular schwannomas: A multicenter study in Japan.,EXCLUDE,Clinical intervention comparison
PMID:39457697,Pheochromocytoma-Paraganglioma Syndrome: A Multiform Disease with Different Genotype and Phenotype Features.,EXCLUDE,Syndrome review
PMID:39482412,TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1.,INCLUDE,Molecular pathway analysis
PMID:39488637,TGF-Î² superfamily-induced transcriptional activation pathways establish the RAD52-dependent ALT machinery during malignant transformation of MPNSTs.,INCLUDE,Molecular transformation mechanism
PMID:39500722,Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.,EXCLUDE,Diagnostic recommendation review
PMID:39514826,"ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.",INCLUDE,Clinical trial of therapeutic intervention
PMID:39518076,Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.,INCLUDE,Cancer stem cell signature identification
PMID:39521772,Automatic construction of Petri net models for computational simulations of molecular interaction network.,INCLUDE,Computational modeling tool
PMID:39539654,Quality of life of patients with neurofibromatosis 1-Physical disability does not necessarily result in poor mental health.,INCLUDE,Quality of life assessment tool
PMID:39548629,Management of high grade primary cerebellar tumours.,EXCLUDE,Tumor management review
PMID:39570085,Adrenocortical tumors and hereditary syndromes.,EXCLUDE,Tumor syndrome review
PMID:39596296,Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.,INCLUDE,Transcriptome profiling method
PMID:39601046,Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.,INCLUDE,Molecular mechanism investigation
PMID:39609892,Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study.,INCLUDE,Neurocognitive assessment tool
PMID:39620202,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,INCLUDE,Multi-omics analysis method
PMID:39666427,[Pituicitoma in a patient with neurofibromatosis type 1].,EXCLUDE,Clinical case report
PMID:39669605,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,INCLUDE,Genetic screening methodology
PMID:39678747,Utility of Keystone Flap in Armory of Dermatosurgeons.,EXCLUDE,Surgical technique description
PMID:39684258,"Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background.",EXCLUDE,Clinical evaluation review
PMID:39712860,Characterization of microRNA-223-3p as a novel promoter of cell proliferation and invasion in papillary thyroid carcinoma.,EXCLUDE,Molecular mechanism review
PMID:39722043,"Cystic lesions and their mimics involving the intrahepatic bile ducts and peribiliary space: diagnosis, complications, and management.",EXCLUDE,Diagnostic review
PMID:39724457,A bibliometric analysis of research trends and hotspots of pilocytic astrocytoma from 2004 to 2023.,EXCLUDE,Bibliometric analysis
PMID:39731295,"Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.",INCLUDE,Drug candidate testing
PMID:39731804,Surgical management of a large neurofibroma in the thenar Region: A case report.,EXCLUDE,Surgical case report
PMID:39749698,SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma.,INCLUDE,Molecular mechanism investigation
PMID:39762421,Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.,INCLUDE,Clinical trial of therapeutic intervention
PMID:39786423,"Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.",INCLUDE,Combination drug screening
PMID:39793045,Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumors.,INCLUDE,Drug resistance prevention method
PMID:39796693,Role of ,EXCLUDE,Incomplete title
PMID:39804140,"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.",INCLUDE,Molecular tumorigenesis mechanism
PMID:39824854,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,INCLUDE,Volume measurement technique comparison
PMID:39835668,"Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary.",INCLUDE,Clinical trial of therapeutic intervention
PMID:39840093,Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS.,INCLUDE,Adverse event signal analysis
PMID:39840811,Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.,INCLUDE,Molecular mechanism investigation
PMID:39841844,WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by ,INCLUDE,Molecular mechanism investigation
PMID:39844170,Internalizing and externalizing symptoms in individuals with neurofibromatosis type 1: a systematic review and meta-analysis.,INCLUDE,Symptom meta-analysis methodology
PMID:39845289,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,INCLUDE,Predictive modeling method
PMID:39857943,UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.,INCLUDE,Molecular mechanism investigation
PMID:39863790,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,INCLUDE,Deep learning tumor identification tool
PMID:39868555,Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration.,INCLUDE,Molecular mechanism investigation
PMID:39875738,[Plastic surgical treatment of neurofibromatosis type 1].,EXCLUDE,Surgical treatment review
PMID:39881370,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",INCLUDE,Computational and spectrophotometric analysis method
PMID:39890807,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,INCLUDE,Proteomics and mass spectrometry analysis method
PMID:39921490,NF2 is Essential for Human Endoderm Development.,INCLUDE,Animal model research
PMID:39948669,How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.,INCLUDE,Clinical assessment tool (EQ-5D-Y)
PMID:39952425,Sex-dependent variations of retinal function and architecture in a neurofibromatosis type I mouse model with normal vision.,INCLUDE,Animal model research
PMID:39965929,Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.,INCLUDE,Animal behavioral model
PMID:39966622,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,INCLUDE,Computational AI tool
PMID:39980445,A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry.,EXCLUDE,Molecular diagnostic technique
PMID:39981185,Schwann cells in regeneration and cancer.,EXCLUDE,Review of Schwann cells
PMID:39996452,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,INCLUDE,Genetic mouse model
PMID:40000831,Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1.,EXCLUDE,Genetic mutation analysis
PMID:40025071,Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.,EXCLUDE,Drug mechanism study
PMID:40025578,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,INCLUDE,CAR-T cell therapy development
PMID:40034205,The evolving landscape of NF gene therapy: Hurdles and opportunities.,EXCLUDE,Gene therapy review
PMID:40043523,Intracytoplasmic accumulation of keratan sulfate is a hallmark of granular cell tumor.,EXCLUDE,Cellular pathology description
PMID:40063513,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,EXCLUDE,Molecular signature analysis
PMID:40075752,Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.,EXCLUDE,Molecular mechanism study
PMID:40087579,Disrupted visual attention relates to cognitive development in infants with Neurofibromatosis Type 1.,EXCLUDE,Cognitive development observation
PMID:40128216,The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.,EXCLUDE,Molecular mechanism study
PMID:40134850,Emerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor development.,EXCLUDE,Therapeutic mechanism review
PMID:40139495,Malignant Peripheral Nerve Sheath Tumors in Children and Adolescents: A Population-Based Study.,EXCLUDE,Epidemiological study
PMID:40140675,Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma.,EXCLUDE,Spatial mapping analysis
PMID:40168468,Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis.,EXCLUDE,Molecular mechanism study
PMID:40169570,A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.,EXCLUDE,Genetic variant analysis
PMID:40172801,From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors.,EXCLUDE,Review of tumor progression
PMID:40188079,"Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation.",EXCLUDE,Molecular interaction study
PMID:40191916,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",INCLUDE,Animal model (biomedical research tool)
PMID:40192953,Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study.,EXCLUDE,Molecular target analysis
PMID:40214469,Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment.,EXCLUDE,Drug mechanism study
PMID:40217315,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,INCLUDE,Single-cell atlas development
PMID:40225101,Small Intestinal Neurofibroma With Atypical 17q11.2 Microdeletions: A Rare Cause of Abdominal Distension.,EXCLUDE,Case report
PMID:40225167,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,INCLUDE,Genetic diagnostic assay
PMID:40235035,Lifelong Management of Neurofibromatosis 1 Patients.,EXCLUDE,Clinical management review
PMID:40237330,Unveiling the complexity of neurofibromatosis type 1: Innovations in genetic understanding and clinical management. A narrative review.,EXCLUDE,Narrative review
PMID:40242369,Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: AÂ Comprehensive Case-Control Analysis.,EXCLUDE,Risk factor analysis
PMID:40279245,Loss of neurofibromin induces inflammatory macrophage phenotypic switch and retinal neovascularization via GLUT1 activation.,EXCLUDE,Molecular mechanism study
PMID:40299482,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,INCLUDE,Clinical assessment tool (sleep assessment)
PMID:40304934,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,INCLUDE,Patient-reported outcome measure development
PMID:40322210,Advanced Metastatic Malignant Triton Tumor in Neurofibromatosis Type 1: A Case Report and Management Challenges.,EXCLUDE,Case report
PMID:40342626,Clinical characterization of neuropathic pain and small fiber impairment in neurofibromatosis.,EXCLUDE,Clinical characterization
PMID:40348863,Multidisciplinary collaborative treatment of a giant malignant peripheral nerve sheath tumor on the top of the head: a case report.,EXCLUDE,Case report
PMID:40352015,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,INCLUDE,Machine learning algorithm development
PMID:40357806,Dentofacial Malocclusion in Neurofibromatosis 1 in Finland.,EXCLUDE,Clinical observation
PMID:40361331,Predictors in Optic Pathway Gliomas in Neurofibromatosis Type 1: A Single Center Study.,EXCLUDE,Clinical study
PMID:40362579,Molecular Dynamics Simulations of the SPRED2,EXCLUDE,Molecular dynamics simulation
PMID:40364967,Transorbital approach for a Meckel's cave hybrid benign tumor: operative video and technical nuances.,EXCLUDE,Surgical technique description
PMID:40380173,Three-column osteotomy versus Halo-gravity traction combined with posterior column osteotomy in the treatment of dystrophic neurofibromatosis type 1 kyphoscoliosis: a retrospective comparative cohort study.,EXCLUDE,Surgical comparative study
PMID:40393479,Neurofibromatosis Type 1 : A General Review.,EXCLUDE,General review
PMID:40394150,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,INCLUDE,Proteomic analysis tool
PMID:40406628,Nipple-Areolar Complex Neurotization Following Nipple-sparing Mastectomy and Breast Reconstruction for Solitary Breast Neurofibroma.,EXCLUDE,Surgical case report
PMID:40408317,"Chronic Pain in Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis: A Review on Epidemiology, Pathophysiology, Symptomatology and Treatment.",EXCLUDE,Clinical review
PMID:40419758,Mirdametinib: First Approval.,EXCLUDE,Drug approval report
PMID:40428382,The Role of Artificial Intelligence in Identifying ,EXCLUDE,Incomplete title
PMID:40437318,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,INCLUDE,MRI quantitative analysis tool
PMID:40459753,"Irritability in children with RASopathies, insights into emotional dysregulation and social impairment.",EXCLUDE,Clinical observation
PMID:40460210,Development of two different eco-friendly label-free platforms for analysis of selumetinib.,INCLUDE,Analytical platform development
PMID:40471421,Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments.,EXCLUDE,Psychosocial study
PMID:40481533,"The association of body image with quality of life, psychological assistance and social support in neurofibromatosis type 1 patients: a cross-sectional study.",EXCLUDE,Cross-sectional study
PMID:40507334,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,INCLUDE,Biomarker platform development
PMID:40518121,RASopathies. Part I: Genetics and therapeutic considerations.,EXCLUDE,Genetic review
PMID:40523834,Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations.,EXCLUDE,Clinical testing recommendation
PMID:40529476,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,INCLUDE,Clinical assessment tool (durometer measurement)
PMID:40532825,RASopathies. Part II: Cutaneous and extracutaneous manifestations.,EXCLUDE,Clinical manifestation review
PMID:40540562,TGFÎ²-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.,EXCLUDE,Molecular mechanism study
PMID:40563570,The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.,INCLUDE,Animal model research
PMID:40567456,Non-invasive brain stimulation reorganises effective connectivity during a working memory task in individuals with Neurofibromatosis Type 1.,EXCLUDE,Brain stimulation study
PMID:40587782,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",INCLUDE,Transcriptomic and functional genetic atlas
PMID:40590220,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,INCLUDE,Animal model research
PMID:40608210,Enhancing care coordination for neurofibromatosis type 1 in primary care: insights and applications for rare diseases.,EXCLUDE,Care coordination review
PMID:40608383,The Combined Use of Acute Regional and Interventional Pain Offers Superior Quality of Life in Palliative Care.,EXCLUDE,Palliative care technique
PMID:40617948,Unraveling novel variants in the NF1 gene and investigating potential therapeutic strategies.,EXCLUDE,Genetic variant study
PMID:40620751,[Long-Term Pulmonary Function after Combined Anteroposterior Spinal Fusion for Scoliosis in Neurofibromatosis Type 1 and Marfan Syndrome at a Mean Follow-Up of 13 Years].,EXCLUDE,Long-term clinical follow-up
PMID:40620752,Long-Term Pulmonary Function after Combined Anteroposterior Spinal Fusion for Scoliosis in Neurofibromatosis Type 1 and Marfan Syndrome at a Mean Follow-Up of 13 Years.,EXCLUDE,Long-term clinical follow-up
PMID:40649916,Skin Signals: Exploring the Intersection of Cancer Predisposition Syndromes and Dermatological Manifestations.,EXCLUDE,Review of cancer syndromes
PMID:40653509,Rare variants modulating phenotype in NF1 carriers.,EXCLUDE,Genetic variant analysis
PMID:40684195,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,EXCLUDE,Developmental mechanism study
PMID:40692699,Knowledge and attitudes about rare genetic diseases among practitioners of oral medicine/pathology in Brazil: a cross-sectional study.,EXCLUDE,Knowledge survey
PMID:40707701,Pyrimidine addiction: an Achilles' heel of NF2-altered mesothelioma.,EXCLUDE,Molecular mechanism study
PMID:40713507,Distinct early development trajectories in Nf1,EXCLUDE,Developmental trajectory study
PMID:40723243,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,EXCLUDE,Drug combination study
PMID:40724874,Preclinical Evaluation of Repurposed Antimalarial Artemisinins for the Treatment of Malignant Peripheral Nerve Sheath Tumors.,EXCLUDE,Preclinical drug evaluation
PMID:40737523,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,INCLUDE,MRI-based volumetric analysis tool
PMID:40741214,"Accounting for Biological Sex and Gender Identity in the Pathogenesis, Artistic Depictions, and Quality of Life in Neurofibromatosis Type 1.",EXCLUDE,Clinical perspective study
PMID:40756144,Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.,EXCLUDE,Molecular mechanism study
PMID:40764996,"From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care.",EXCLUDE,Clinical management review
PMID:40769067,Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.,INCLUDE,Biomarker development
PMID:40802118,Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.,EXCLUDE,Clinical drug experience report
PMID:40842566,Translocator protein deficiency blocks the ferroptosis of malignant peripheral nerve sheath tumors through glutathione peroxidase 4.,EXCLUDE,Molecular mechanism study
PMID:40842873,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,INCLUDE,Imaging analysis method
PMID:40843672,Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.,EXCLUDE,Epigenetic mechanism review
PMID:40849244,A consensus on the diagnosis and management of neurofibromatosis type 1 in Taiwan.,EXCLUDE,Clinical consensus document
PMID:40862755,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,INCLUDE,3D culture model
PMID:40867225,Optic Pathway Glioma: Current Treatment Approaches and Ongoing Clinical Trials.,EXCLUDE,Treatment review
PMID:40877908,TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells.,EXCLUDE,Molecular mechanism study
PMID:40887659,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,INCLUDE,Genetic variant prediction tool
PMID:40894429,Olfactory Groove Meningiomas and the Association with Postoperative Weight Loss.,EXCLUDE,Clinical observation
PMID:40896930,High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.,INCLUDE,Imaging diagnostic technique
PMID:40940846,Repair of Mutated ,EXCLUDE,Incomplete title
PMID:40977920,Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring.,INCLUDE,Computational diagnostic method
PMID:40979205,Progress in genetic mechanisms and precise treatment of neurocutaneous syndrome-related epilepsy.,EXCLUDE,Epilepsy mechanism review
PMID:40991947,Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.,EXCLUDE,Drug review
PMID:40992926,"Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas.",EXCLUDE,Drug mechanism study
PMID:41001135,"Schwann cells in the inner ear: development, disease, and regeneration.",INCLUDE,Schwann cell research tool
PMID:41001593,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,INCLUDE,Gene expression analysis tool
PMID:41022755,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,INCLUDE,Gene therapy vector development
PMID:41023593,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,INCLUDE,Drug sensitivity screening method
PMID:41036607,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,INCLUDE,Pharmacogenomic screening approach
PMID:41036990,[Neurofibromatosis: advances in diagnosis and treatment].,EXCLUDE,Review article
PMID:41053414,Natural history of SPP1 signaling in NF1 tumors.,EXCLUDE,Natural history observation
PMID:41078618,Expanding the Genetic Landscape of RASopathies: Significance of Including ,EXCLUDE,Genetic landscape review
PMID:41124475,"Quality of life of adolescent, children and young adults with neurofibromatosis type 1: a scoping review.",EXCLUDE,Systematic review
PMID:41141169,Incidental Adrenal Mass in a Patient With a Known History of Neurofibromatosis: A Case Report.,EXCLUDE,Clinical case report
PMID:41149489,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,INCLUDE,Extracellular vesicle research tool
PMID:41155378,Neurofibromin Encoded by the ,EXCLUDE,Incomplete title
PMID:41168866,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,INCLUDE,AI diagnostic tool development
PMID:41210219,Radiation sensitivity in genetic tumour syndromes and how to test for them.,INCLUDE,Radiation sensitivity testing method
PMID:41211508,Ambient ionization mass spectrometry in brain cancer diagnosis.,INCLUDE,Mass spectrometry diagnostic tool
PMID:41223283,Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.,INCLUDE,Animal model research
PMID:41226361,CDK4/6 Inhibitors in Breast Cancer-Who Should Receive Them?,EXCLUDE,Cancer treatment review
PMID:41243511,A novel germline ,EXCLUDE,Incomplete title
PMID:41294711,Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.,INCLUDE,High-throughput drug screening
PMID:41299544,Clinical characteristics and healthcare burden of neurofibromatosis type 1 in Saudi Arabia: a single centre experience.,EXCLUDE,Clinical characteristics study
PMID:41340880,"Bibliometric Analysis of Global Research on Cafe-Au-Lait Macules from 2000 to 2025: Development, Collaboration Patterns, and Emerging Trends.",EXCLUDE,Bibliometric analysis
PMID:41341331,"Optic Nerve Glioma, Plexiform Neurofibroma, and Secondary Glaucoma in a Child With a Rare NF1 Variant (p.Gln83Ter): A Case Report.",EXCLUDE,Clinical case report
PMID:41374983,Challenges and Progress for Treatment of Malignant Peripheral Nerve Sheath Tumors in the Context of Recent Successes for Sarcoma Therapy.,EXCLUDE,Treatment review
PMID:41374990,Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation.,EXCLUDE,Genetic mechanisms review
PMID:41397954,Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1.,INCLUDE,Animal model research
PMID:41399671,Phenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study.,EXCLUDE,Phenotypic characterization study
PMID:41411243,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,INCLUDE,Computational disease mapping tool
PMID:41437121,The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis.,EXCLUDE,Tumor microenvironment analysis
PMID:41444363,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,INCLUDE,Animal model drug delivery
PMID:41463204,The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications.,EXCLUDE,Pathogenesis review
PMID:41468561,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,INCLUDE,Clinical assessment tool (growth charts)
PMID:41480763,NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress.,INCLUDE,Cell transformation model
PMID:41480769,Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment.,EXCLUDE,Mechanistic cancer review
PMID:41487565,Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma.,EXCLUDE,Targeting strategy review
PMID:41487805,Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma.,EXCLUDE,Clinical case report
PMID:41496278,Simultaneous reprogramming and gene correction to generate six iPSC lines and isogenic controls from individuals with neurofibromatosis type 1.,INCLUDE,iPSC generation and gene correction
PMID:41496346,"Midkine as a therapeutic node in NF1-driven neuroâoncology: Biology, biomarkers, and translational strategies.",EXCLUDE,Therapeutic strategy review
PMID:41527138,Prevalence and management of lower limb segmental overgrowth in patients with NF1: an observational study.,EXCLUDE,Clinical management study
PMID:41533509,Microenvironmental TGF-Î² is an early driver of NF1-associated tumor formation.,EXCLUDE,Tumor microenvironment analysis
PMID:41545416,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,INCLUDE,Mathematical modeling tool
PMID:41564118,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,INCLUDE,Cell line development
PMID:41570527,Novel insights into the regulation of NF2/SWH signaling in granulosa cells of prehierarchical follicle development in hen ovary.,EXCLUDE,Signaling pathway analysis
PMID:41580779,HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.,EXCLUDE,Molecular progression study
PMID:41582719,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of Neurofibromatosis.,INCLUDE,Zebrafish disease model
PMID:41591566,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,INCLUDE,Tumor characterization method
PMID:41594582,Caffeine May Delay the Radiation-Induced Nucleoshuttling of the ATM Kinase and Reduce the Recognition of the DNA Double-Strand Breaks in Human Cells.,EXCLUDE,Radiation mechanism study
PMID:41598414,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,INCLUDE,Imaging diagnostic tool
PMID:41602242,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,INCLUDE,Clinical assessment tool (pain questionnaire)
PMID:41616055,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,INCLUDE,Animal model research
PMID:41631643,Disrupted Frontoparietal Dynamics in Neurofibromatosis Type 1: Reduced Sensitivity and Atypical Modulation During Working Memory.,EXCLUDE,Neuroimaging analysis
PMID:41675655,Matrix Metalloproteinaseâ9 (MMP-9) Activatable Gold Nanoparticles for ,EXCLUDE,Incomplete title
PMID:41680443,Proof-of-principle of NF1 gene therapy in plexiform neurofibroma xenograft mouse models.,INCLUDE,Gene therapy xenograft model
PMID:41687459,From diagnosis to daily life: A comparative pilot study on healthcare access and challenges for neurofibromatosis type 1 in public systems of Brazil and Portugal.,EXCLUDE,Healthcare access study
PMID:4327710,Complications of mediastinal neural tumours.,INCLUDE,Parse error - defaulted to include
PMID:4371739,Tumours of the nervous system.,INCLUDE,Parse error - defaulted to include
PMID:4604946,Primary mediastinal tumours.,INCLUDE,Parse error - defaulted to include
PMID:4622580,Recent advances in neuroblastoma.,INCLUDE,Parse error - defaulted to include
PMID:5003511,Neurofibromatosis and leprosy.,INCLUDE,Parse error - defaulted to include
PMID:5282620,Electron microscopic observations on structures resembling myxovirus in human sarcomas.,INCLUDE,Parse error - defaulted to include
PMID:6093111,Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.,INCLUDE,Antibody development
PMID:6139138,Multiple endocrine neoplasia associated with von Recklinghausen's disease.,INCLUDE,Parse error - defaulted to include
PMID:6168641,Effect of interferon in therapy of skin and head and neck tumors.,INCLUDE,Parse error - defaulted to include
PMID:6203987,Neurofibromatosis of von Recklinghausen: a quantitative study of the epidermal keratinocyte and melanocyte populations.,INCLUDE,Parse error - defaulted to include
PMID:6278936,S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes.,INCLUDE,Parse error - defaulted to include
PMID:6413007,Tumors of the peripheral nervous system.,INCLUDE,Parse error - defaulted to include
PMID:6417334,Linkage analysis of neurofibromatosis (von Recklinghausen disease).,INCLUDE,Parse error - defaulted to include
PMID:6432917,The nature and origin of the melanin macroglobule.,INCLUDE,Parse error - defaulted to include
PMID:6451216,An enzyme activity in normal and ataxia telangiectasia cell lines which is involved in the repair of gamma-irradiation-induced DNA damage.,INCLUDE,Parse error - defaulted to include
PMID:6490532,The effects of mesencephalic neural crest cell extirpation on the development of chicken embryos.,INCLUDE,Parse error - defaulted to include
PMID:6523094,An evaluation of reports of dioxin exposure and soft tissue sarcoma pathology among chemical workers in the United States.,INCLUDE,Parse error - defaulted to include
PMID:666085,Scanning electron microscopy of nerve sheath neoplasms.,INCLUDE,Parse error - defaulted to include
PMID:6810767,CafÃ©-au-lait spots in schoolchildren.,INCLUDE,Parse error - defaulted to include
PMID:7426572,Primary optic nerve meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7474134,Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.,INCLUDE,Parse error - defaulted to include
PMID:7485397,Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.,INCLUDE,Parse error - defaulted to include
PMID:7485407,NF2 gene analysis distinguishes hemangiopericytoma from meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7493911,Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers.,INCLUDE,Parse error - defaulted to include
PMID:7499408,"Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.",INCLUDE,Parse error - defaulted to include
PMID:7505343,"Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.",INCLUDE,Parse error - defaulted to include
PMID:7570581,"Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.",INCLUDE,Parse error - defaulted to include
PMID:7609078,Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.,INCLUDE,Parse error - defaulted to include
PMID:7671302,Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.,INCLUDE,Parse error - defaulted to include
PMID:7686513,An exon-trapping system with a newly constructed trapping vector pEXT2; its application to the proximal region of the human chromosome 21 long arm.,INCLUDE,Parse error - defaulted to include
PMID:7686619,Multiple dispersed loci produce small cytoplasmic Alu RNA.,INCLUDE,Parse error - defaulted to include
PMID:7706208,An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.,INCLUDE,Parse error - defaulted to include
PMID:7717450,Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.,INCLUDE,Parse error - defaulted to include
PMID:7818486,Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression.,INCLUDE,Parse error - defaulted to include
PMID:7903272,An EcoRI RFLP in the 5' region of the human NF1 gene.,INCLUDE,Parse error - defaulted to include
PMID:7911002,Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.,INCLUDE,Parse error - defaulted to include
PMID:7947085,"Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.",INCLUDE,Parse error - defaulted to include
PMID:7947096,Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.,INCLUDE,Parse error - defaulted to include
PMID:7949098,Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.,INCLUDE,Parse error - defaulted to include
PMID:7959746,DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse.,INCLUDE,Parse error - defaulted to include
PMID:7977647,Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans.,INCLUDE,Parse error - defaulted to include
PMID:7985572,Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.,INCLUDE,Parse error - defaulted to include
PMID:7996175,Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas.,INCLUDE,Parse error - defaulted to include
PMID:803743,Vascular manifestations of von Recklinghausen's disease.,INCLUDE,Parse error - defaulted to include
PMID:8051082,Cloning and characterization of a novel epidermal cell surface antigen (ESA).,INCLUDE,Parse error - defaulted to include
PMID:8089100,An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).,INCLUDE,Parse error - defaulted to include
PMID:8105688,Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping.,INCLUDE,Parse error - defaulted to include
PMID:817416,Studies on cafÃ© au lait spots in neurofibromatosis and pigmented macules of nevus spilus.,EXCLUDE,Descriptive clinical observation
PMID:8176268,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,INCLUDE,Protein localization method
PMID:8176761,Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.,INCLUDE,Gene expression analysis
PMID:8226742,The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.,INCLUDE,Molecular biology research tool
PMID:8226805,Purification of a novel ras GTPase-activating protein from rat brain.,INCLUDE,Protein purification method
PMID:8246952,Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.,INCLUDE,Molecular interaction analysis
PMID:8264632,Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.,INCLUDE,Molecular biology research method
PMID:8318482,Lens opacities in neurofibromatosis 2: further significant correlations.,EXCLUDE,Clinical observation
PMID:8320697,A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.,INCLUDE,Genetic diagnostic method
PMID:8328449,An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.,INCLUDE,Genetic variation analysis
PMID:8332934,Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.,INCLUDE,Protein interaction research
PMID:8335107,Differential contribution of M(r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity.,INCLUDE,Cell growth regulation method
PMID:8341688,Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.,INCLUDE,Molecular genetics research
PMID:8374583,Information resources at the National Center for Biotechnology Information.,EXCLUDE,Information resource description
PMID:8417346,"A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.",INCLUDE,Molecular biology splice variant analysis
PMID:8432898,Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.,EXCLUDE,Descriptive pathology observation
PMID:8455625,Differential regulation of cellular activities by GTPase-activating protein and NF1.,INCLUDE,Cellular activity research method
PMID:8520280,Introducing the Internet.,EXCLUDE,Technology introduction
PMID:8544190,Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.,INCLUDE,Genetic mutation characterization
PMID:8582272,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,INCLUDE,Cell culture research method
PMID:8602361,The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.,INCLUDE,RNA modification analysis
PMID:8612763,Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase.,INCLUDE,Protein modification research
PMID:8621451,A naturally occurring T14A11 tract blocks nucleosome formation over the human neurofibromatosis type 1 (NF1)-Alu element.,INCLUDE,Genetic sequence analysis
PMID:8627811,Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.,INCLUDE,Genetic regulation research
PMID:8659521,Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus.,INCLUDE,Genetic typing method
PMID:8666669,"Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin.",INCLUDE,Molecular biology comparative analysis
PMID:8719681,Retinal changes associated with neurofibromatosis 2.,EXCLUDE,Clinical observation
PMID:8719691,Neurofibromatosis type 1 in children.,EXCLUDE,Clinical review
PMID:8730197,Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.,EXCLUDE,Clinical imaging observation
PMID:8751853,Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.,INCLUDE,Genetic mutation analysis
PMID:8756677,"Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein alpha subunit).",EXCLUDE,Yeast genetics unrelated to NF
PMID:8825042,Molecular genetics of neurofibromatosis type 1 (NF1).,EXCLUDE,Review of molecular genetics
PMID:8825915,Psychological aspects of von Recklinghausen neurofibromatosis (NF1).,EXCLUDE,Psychological review
PMID:8892969,NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.,INCLUDE,Gene expression analysis
PMID:8982875,Differential tissue-specific expression of neurofibromin isoform mRNAs in rat.,INCLUDE,Tissue-specific gene expression
PMID:9001241,Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.,INCLUDE,Animal model research
PMID:9036924,Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.,INCLUDE,Cell culture research method
PMID:9055157,Tribute--and a clinical lesson in bioethics and quality of life.,EXCLUDE,Clinical ethics commentary
PMID:9078372,Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.,INCLUDE,Transgenic animal model
PMID:9136014,Isolation of mutations in the Drosophila homologues of the human Neurofibromatosis 2 and yeast CDC42 genes using a simple and efficient reverse-genetic method.,INCLUDE,Genetic mutation isolation method
PMID:9161732,Neurofibromatosis 1 and 2.,EXCLUDE,Clinical review
PMID:9222967,Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.,INCLUDE,Genetic mutation analysis
PMID:9258610,Damselfish with neurofibromatosis exhibit cytotoxicity towards retrovirus infected cells.,EXCLUDE,Animal observation
PMID:9321761,Uptake of genetic testing for cancer predisposition.,EXCLUDE,Genetic testing review
PMID:932744,Epidemiology of primary tumours of the brain and spinal cord: a regional survey in southern England.,EXCLUDE,Epidemiological survey
PMID:9391890,Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.,EXCLUDE,Clinical genetic testing observation
PMID:9399891,Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.,INCLUDE,Molecular genetic analysis
PMID:9407121,"Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase.",EXCLUDE,Gene characterization
PMID:9430655,"NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.",INCLUDE,Protein interaction research
PMID:9458162,A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.,INCLUDE,Molecular biology method
PMID:9504491,Curved reconstruction along the anterior optic pathway.,EXCLUDE,Clinical imaging technique
PMID:9516485,"Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.",INCLUDE,Protein regulation research
PMID:9560242,A role for Pak protein kinases in Schwann cell transformation.,INCLUDE,Cell transformation research
PMID:9607929,Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.,INCLUDE,Hematopoietic cell research
PMID:9640961,Microsurgical treatment of intramedullary spinal cord tumors.,EXCLUDE,Surgical procedure description
PMID:9687500,Structural analysis of the GAP-related domain from neurofibromin and its implications.,INCLUDE,Protein structural analysis
PMID:9703963,Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.,INCLUDE,Protein interaction research
PMID:9707592,Mutation frequency declines during spermatogenesis in young mice but increases in old mice.,EXCLUDE,Mutation frequency observation
PMID:9719366,Bony orbital morphology in neurofibromatosis type 1 (NF1).,EXCLUDE,Clinical morphology observation
PMID:9878702,Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.,INCLUDE,Animal model research
